Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AC004922.1		ENSG00000284292			7	99325879-99394653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004334	Uncertain		Approved	"Cell Junctions,Cytosol"				"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"																		6.0	5.2	4.2	9.4	6.2	6.9	7.8	3.2	9.1	5.3	6.6	4.6	5.6	13.8	5.8	3.8	5.3	5.0	4.5	4.9	7.1		4.1	6.3	4.6	8.1	3.2	6.0	3.9	6.4	3.0	4.1	5.2	6.2	5.0	3.1	4.9	3.3	5.4	4.6	2.4	9.6	4.2	3.0	6.5	7.0	3.9	3.2	2.9	6.0	6.4	4.4	4.6	4.1	7.9	13.0	18.1	16.3	5.1	11.9	18.0	4.1	3.9	0.4	1.0	0.5	2.8	5.0	3.3	1.8	3.0	3.1	7.1	5.8	4.4	10.8	3.4	2.8	1.2	3.7	0.6	2.1	7.4	2.5	2.9	1.9	0.9	2.7	3.1	2.6	1.1	3.1	1.2	4.3	3.8	4.0	2.1	7.8	4.8	1.2	2.6	11.8	2.1	1.1	1.5	0.6	2.0	1.1	1.0	2.8	4.6	8.3	2.1	1.7	2.9	4.8	2.6	7.1	4.2	0.0	2.2	4.7	2.9	4.1	5.7	9.2	15.5	18.1	7.1	16.3	5.1	7.3	7.0	6.9	13.0	7.9	6.1	6.1	13.9	5.1	15.0	8.9	11.9	18.0										
ADGRL2	"KIAA0786, LEC1, LPHH1, LPHN2"	ENSG00000117114	"Adhesion G protein-coupled receptor L2"	O95490	1	81306160-81992436	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 62.8;hTEC/SVTERT24-B: 31.2;NTERA-2: 26.3;SH-SY5Y: 42.1;U-2197: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043447			Approved	"Plasma membrane,Cell Junctions"			280000	"Plasma membrane, Cell Junctions"		"HPA043447: AB_2678486"	"unprognostic (2.54e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (9.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.81e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.76e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.41e-2)"	8.9	10.5	21.1	3.6	20.9	0.0	8.8	1.5	45.8	7.5	7.0	1.4	1.2	2.7	6.1	8.6	12.0	12.0	11.5	17.6	12.2	6.6	10.9	18.7	32.7	3.5	3.5	22.8	18.8	4.9	20.3	11.8	24.4	6.2	15.6	5.4	9.4	19.1	10.1	2.0	6.3	6.1	6.0	3.2	10.0	7.6	2.0	3.3	0.6	22.4	15.0	5.0	6.5	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.3	62.8	0.0	7.8	8.9	0.8	1.5	3.5	0.6	0.7	0.0	0.0	0.0	17.2	8.0	2.5	5.0	6.6	0.5	0.1	10.2	0.0	1.8	4.4	2.9	0.0	0.1	7.6	0.4	31.2	3.1	10.3	0.0	0.0	0.8	0.0	0.0	0.0	26.3	1.8	0.0	8.6	0.0	14.3	0.9	3.1	42.1	0.0	1.7	0.0	0.1	18.5	6.7	6.4	7.3	28.7	2.2	0.0	0.0	0.0	3.6	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	20.9	1.5	45.8	12.2	6.6	3.5	22.8	6.2	3.3
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute 2, RISC catalytic component"	Q9UKV8	8	140520156-140635619	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA058075"	Approved		Supported	"Nucleoplasm,Cell Junctions"			35000000	"Nucleoplasm, Cell Junctions"		"CAB019309: , HPA058075: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	11.2	6.6	7.7	9.9	13.1	16.2	25.0	9.9	11.4	7.5	9.2	12.1	12.8	5.3	10.2	10.4	10.6	8.6	8.8	12.4	8.8	5.3	6.9	7.4	13.2	12.5	13.4	5.0	11.8	8.4	13.2	8.8	9.9	10.7	7.5	6.9	5.6	8.1	12.6	37.1	14.1	7.5	15.0	11.7	6.9	10.0	5.9	12.7	11.1	8.6	8.2	8.9	10.4	18.4	2.5	2.1	6.4	2.6	2.4	3.0	1.5	12.6	10.5	10.8	12.3	7.1	8.4	9.1	8.0	5.8	3.6	4.5	11.6	3.8	14.6	10.1	7.7	8.6	18.2	8.6	8.0	8.2	9.5	17.1	18.0	7.4	6.4	7.0	5.8	5.7	7.8	10.0	10.4	8.3	17.8	9.2	11.7	19.2	12.1	5.6	8.0	18.3	12.5	9.1	6.6	4.6	13.2	12.7	9.2	12.5	4.3	8.9	11.0	10.3	11.6	6.3	17.5	9.8	12.8	8.2	2.6	10.3	4.6	12.8	9.2	1.8	2.6	0.7	2.7	2.3	3.0	1.3	2.6	2.3	2.1	2.5	2.7	2.7	6.4	2.4	2.3	1.5	2.1	1.5	7.7	13.1	9.9	11.4	8.8	5.3	13.4	5.0	10.7	12.7
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.0;epididymis: 102.0"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA067290: , HPA067853: "	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favourable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	3.7	2.3	18.4	2.0	17.9	1.3	5.5	3.0	14.0	8.1	3.5	13.9	40.0	3.1	4.7	102.0	3.8	9.7	3.1	3.7	15.4	10.9	8.2	2.5	3.0	1.6	14.4	10.3	5.4	2.7	8.4	7.0	14.9	18.0	5.6	4.3	1.2	6.9	27.6	25.2	2.7	3.6	3.5	15.7	2.1	3.3	2.7	13.5	0.1	3.8	9.3	1.8	3.2	4.3	0.5	0.2	0.0	0.6	1.9	1.5	0.2	3.0	0.0	17.6	0.7	0.3	0.3	6.5	0.6	0.0	0.0	0.0	7.4	0.6	0.4	3.6	2.7	6.4	19.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	3.9	0.5	0.1	0.0	0.0	0.4	0.3	4.8	0.2	7.8	0.1	6.1	5.4	0.1	8.2	8.1	0.0	6.0	0.1	0.0	6.8	0.6	0.1	0.1	2.2	5.2	0.0	7.0	0.5	0.0	0.0	0.8	0.1	4.5	0.0	0.0	0.0	1.1	0.4	1.5	0.5	0.7	1.0	0.2	0.2	0.7	0.6	0.0	1.9	0.6	0.2	1.0	0.2	18.4	17.9	3.0	14.0	15.4	10.9	14.4	10.3	18.0	13.5
AMOTL1	JEAP	ENSG00000166025	"Angiomotin like 1"	Q8IY63	11	94706431-94876753	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 36.0;WM-115: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3;NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001196	Approved		Approved	"Cell Junctions,Cytosol"			11000	Cytosol	"Cell Junctions"	"HPA001196: AB_1078147"	"unprognostic (2.21e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (5.03e-6)"	"unprognostic (7.47e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.29e-2)"	14.4	5.7	3.3	6.9	4.0	0.6	9.2	3.7	4.8	12.8	15.4	2.7	9.1	2.2	16.4	11.4	19.3	7.5	10.9	10.1	3.1	3.9	4.4	4.8	10.0	2.5	3.2	2.5	7.3	10.8	13.5	13.9	25.4	3.5	18.7	4.0	11.3	8.9	13.6	78.2	11.7	4.8	32.8	2.6	6.2	8.1	7.1	1.8	12.9	8.6	21.9	10.1	24.4	9.5	2.3	1.0	0.0	0.7	2.3	0.1	0.5	18.0	5.1	13.8	0.0	14.9	12.9	6.6	10.0	17.5	4.6	5.4	9.4	0.5	0.8	4.9	13.5	23.5	6.5	36.0	4.8	1.4	5.0	9.7	5.4	0.0	3.4	2.1	0.0	7.6	22.3	15.7	26.3	9.5	24.5	0.9	10.8	5.2	6.6	1.3	2.0	3.4	0.0	25.1	1.5	6.5	7.6	10.5	12.7	0.6	13.9	3.6	0.7	3.0	8.7	12.6	9.3	0.2	6.8	0.5	0.0	5.1	3.5	0.0	34.4	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.6	2.3	0.0	0.0	0.0	2.3	0.2	1.0	0.0	0.5	3.3	4.0	3.7	3.0	3.1	3.9	3.2	2.5	3.5	1.8
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852038-26865818	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 185.1;lung: 53.5"	"Cell line enhanced"	"Detected in some"		"AF22: 6.7;Karpas-707: 2.0;RPTEC TERT1: 3.8;U-87 MG: 1.7"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: , HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0.0	1.6	1.6	2.0	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2.0	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0.0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0.0	8.4	0.1	1.6	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325910-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"			2400000	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	36.6	39.8	40.2	25.2	41.0	18.7	49.1	32.3	55.9	40.0	43.6	32.3	37.9	50.1	30.4	45.9	58.3	43.3	32.1	65.3	45.9	43.5	30.6	41.2	29.6	32.2	38.6	39.7	47.2	41.9	30.9	31.4	31.8	40.6	28.2	44.2	33.9	31.7	36.7	20.9	46.1	55.0	31.9	27.9	26.8	53.1	28.6	25.1	23.7	44.4	41.8	31.6	31.5	33.9	11.1	16.1	33.2	29.1	10.9	12.6	9.9	45.4	24.8	28.2	12.9	26.3	44.8	24.0	32.7	38.4	33.4	33.3	27.8	52.5	15.9	48.4	39.7	19.3	36.9	47.5	40.4	7.9	31.1	8.5	18.5	22.4	29.0	10.0	11.2	41.6	26.6	43.0	46.0	54.6	21.3	18.5	51.2	66.5	16.7	13.4	26.4	56.1	9.9	19.5	19.5	24.8	27.6	29.1	24.9	32.0	46.0	43.6	23.0	14.8	42.3	42.8	38.4	75.4	52.1	7.2	13.2	22.6	37.0	22.5	56.1	33.2	18.9	31.9	9.8	28.6	7.6	11.0	9.3	12.6	16.1	11.1	12.1	9.1	23.8	10.9	29.1	11.7	12.1	9.9	40.2	41.0	32.3	55.9	45.9	43.5	38.6	39.7	40.6	25.1
ARVCF		ENSG00000099889	"ARVCF, delta catenin family member"	O00192	22	19969896-20016808	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.8"	"Cell line enhanced"	"Detected in many"		"K-562: 15.4;SCLC-21H: 14.7;SH-SY5Y: 11.3;U-2 OS: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016162, HPA055264, HPA063675"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"CAB016162: AB_2058690, HPA055264: , HPA063675: "	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (5.76e-6)"	3.4	6.6	9.0	1.8	6.1	6.0	3.2	30.8	11.1	3.4	3.2	7.7	3.5	2.7	4.2	14.6	3.1	2.6	8.0	6.2	8.1	8.1	5.0	4.9	3.9	1.4	3.8	6.8	2.9	8.7	4.9	7.3	2.7	5.9	6.1	1.1	6.4	8.7	4.6	13.4	5.3	3.7	3.6	4.0	13.4	5.2	5.2	2.8	0.5	12.1	1.6	1.5	2.8	1.8	0.0	0.6	0.0	0.2	0.7	1.2	0.8	3.2	0.3	4.4	5.7	0.0	0.0	4.6	0.8	0.3	0.2	0.5	0.9	0.7	1.3	3.6	0.4	3.0	0.7	1.4	0.0	0.4	5.5	0.4	0.3	3.4	1.3	0.4	1.0	0.1	0.5	0.2	0.2	3.6	15.4	0.4	0.0	2.9	0.2	2.0	4.5	1.8	8.2	0.2	0.4	0.8	0.7	14.7	11.3	0.9	1.4	2.2	1.2	0.3	1.3	0.1	12.9	0.5	0.3	1.8	0.5	0.4	0.2	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	1.2	0.0	0.7	0.0	0.6	0.0	0.8	9.0	6.1	30.8	8.9	8.1	8.1	3.8	6.8	5.9	2.8
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 171.0"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 102.0"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 13.7;monocytes: 39.1"	"Region enriched"	"Detected in many"	9	"cerebellum: 49.4"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Intracellular and membrane"			Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171.0	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0.0	0.1	2.0	0.9	0.0	0.0	0.1	0.1	0.1	0.2	0.3	3.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.3	102.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	1.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0.0	0.0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2
BRK1	"C3orf10, HSPC300, MDS027"	ENSG00000254999	"BRICK1, SCAR/WAVE actin nucleating complex subunit"	Q8WUW1	3	10115592-10127190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060391			Approved	"Nuclear speckles,Cell Junctions"			130000	"Nuclear speckles"	"Cell Junctions"	"HPA060391: "	"unprognostic (4.99e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.75e-3)"	67.1	47.6	53.4	40.4	57.1	52.4	62.9	33.4	69.5	52.8	58.6	36.1	47.3	37.9	63.2	68.3	73.0	59.4	70.8	54.4	42.6	45.3	66.8	57.3	49.3	53.2	43.3	53.6	62.7	57.8	38.8	39.2	44.4	40.7	60.8	51.8	41.5	84.2	53.1	62.7	57.0	46.5	74.3	37.2	47.0	57.2	65.2	34.2	50.2	83.3	62.4	64.8	63.0	61.0	67.4	89.7	76.1	75.4	47.2	61.0	89.1	30.1	36.2	38.6	20.0	64.6	70.6	91.4	44.9	44.8	42.2	42.0	24.8	35.5	34.8	21.4	51.6	15.8	27.7	45.5	46.3	38.3	38.4	48.0	41.8	36.9	36.8	45.6	36.4	46.3	44.1	47.2	34.4	58.8	31.1	40.8	63.6	66.3	29.5	36.5	44.4	45.9	28.6	39.7	37.8	55.5	50.1	15.0	26.1	36.1	31.5	36.3	51.2	40.0	53.1	42.5	32.6	49.7	40.0	23.5	63.0	78.5	61.5	62.7	34.9	54.1	75.4	75.9	56.5	72.4	50.3	67.4	55.0	53.1	84.3	67.4	50.1	54.4	76.1	47.2	70.9	89.7	61.0	89.1	53.4	57.1	33.4	69.5	42.6	45.3	43.3	53.6	40.7	34.2
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137174	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.3;skeletal muscle: 37.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.4;WM-115: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;granulocytes: 2.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	1.0	2.3	2.4	7.6	0.6	8.9	0.7	4.1	2.6	11.5	6.7	6.7	1.7	5.3	2.8	5.3	2.5	2.1	29.3	2.8	2.5	1.5	0.7	2.3	0.9	10.4	1.3	1.2	1.0	0.8	3.5	3.5	6.1	5.4	3.5	3.6	1.6	10.0	37.1	0.8	2.7	19.4	10.7	0.7	5.9	10.0	6.3	0.0	1.6	8.6	0.8	10.3	8.6	0.5	1.2	2.9	0.3	0.4	0.4	0.1	0.8	1.2	4.7	0.8	6.9	9.5	2.1	3.5	2.5	5.5	7.3	0.3	0.0	0.0	0.0	6.6	0.0	2.0	1.2	5.1	0.0	1.7	0.0	0.6	0.2	1.5	0.0	0.3	5.5	4.3	8.5	0.7	2.4	0.0	11.9	12.1	0.1	0.1	0.6	1.0	0.0	3.4	18.4	0.0	0.0	0.0	6.2	10.7	2.2	0.0	4.7	0.0	12.0	5.4	8.8	0.0	0.0	9.2	1.1	0.4	0.0	5.2	0.0	18.5	2.9	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.4	0.0	0.5	0.3	0.3	1.7	0.4	0.1	1.2	0.1	0.1	2.3	7.6	0.7	4.1	2.8	2.5	10.4	1.3	6.1	6.3
C17orf62	"FLJ90469, MGC4368"	ENSG00000178927	"Chromosome 17 open reading frame 62"	Q9BQA9	17	82442589-82450829	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045696	Uncertain		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA045696: "	"unprognostic (1.87e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.81e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (6.83e-11)"	"unprognostic (1.47e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.14e-3)"	19.9	17.3	16.8	35.8	25.2	16.4	20.0	8.6	20.4	16.2	16.2	20.8	10.5	12.1	16.5	13.1	17.1	16.0	22.9	12.1	15.2	12.1	17.5	29.1	20.2	48.3	26.8	12.4	17.6	21.3	12.9	15.7	14.9	20.6	19.5	13.6	12.2	14.7	12.7	6.5	13.9	21.1	20.2	19.0	53.7	16.4	8.3	20.9	26.0	13.8	8.2	42.3	29.2	13.3	30.6	33.0	74.9	44.2	24.2	25.9	34.6	14.0	20.5	11.3	18.6	17.9	18.8	11.0	12.7	15.4	18.7	22.3	7.6	14.3	35.7	11.7	17.9	14.2	7.7	9.5	12.9	25.4	6.3	9.7	6.7	8.9	18.6	10.9	28.7	21.7	13.8	16.0	9.0	24.2	8.1	26.8	15.7	15.6	45.2	9.2	8.6	11.0	34.6	6.8	27.4	13.8	17.9	9.7	18.4	22.9	26.8	16.3	27.5	43.9	8.3	14.6	14.3	23.9	13.4	49.0	16.3	26.3	19.0	17.8	12.8	43.8	34.1	44.0	25.9	44.2	20.0	30.2	23.9	25.0	31.4	30.6	20.2	19.6	74.9	24.2	39.6	33.0	24.8	34.6	16.8	25.2	8.6	20.4	15.2	12.1	26.8	12.4	20.6	20.9
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494030-151621193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.4;fallopian tube: 33.0"	"Group enriched"	"Detected in some"	5	"MCF7: 13.8;T-47d: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.1"	"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"				"Golgi apparatus"	"Cell Junctions"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	6.2	2.1	1.4	6.7	0.3	4.0	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33.0	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0.0	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	8.1	0.1	0.8	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0.0	0.0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5
CCDC85C		ENSG00000205476	"Coiled-coil domain containing 85C"	A6NKD9	14	99500180-99604026	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058346	Uncertain		Approved	"Nuclear speckles,Cell Junctions"				"Nuclear speckles, Cell Junctions"		"HPA058346: "	"unprognostic (7.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (5.70e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.68e-3)"	"prognostic favourable (2.60e-5)"	"unprognostic (4.14e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.81e-3)"	3.5	12.0	13.9	3.3	15.5	7.2	6.1	45.2	11.8	11.3	15.3	11.7	16.6	15.4	8.7	12.6	24.0	10.0	13.9	11.4	11.6	7.6	7.8	32.3	6.7	1.9	10.3	5.9	6.9	15.3	10.4	10.0	7.1	9.1	15.8	9.5	19.9	20.8	14.8	15.2	13.6	27.0	15.4	8.4	3.0	10.5	8.1	8.1	2.7	9.5	9.3	8.7	13.7	17.9	0.3	0.1	0.7	0.0	0.4	2.0	0.6	17.3	15.9	19.8	11.8	0.2	0.0	18.4	5.9	6.0	11.9	6.9	19.3	18.4	0.1	23.4	6.6	23.4	14.6	14.1	7.4	28.5	8.6	0.9	15.8	13.0	1.6	0.2	1.8	0.0	7.5	3.4	9.8	3.7	4.2	2.6	1.4	29.0	7.7	2.3	7.2	16.6	11.6	8.3	3.9	8.4	6.9	9.8	12.3	15.0	8.0	3.6	17.5	3.5	8.3	2.3	19.8	8.4	5.8	4.2	5.5	0.1	0.4	1.5	1.6	0.7	0.0	0.0	0.6	0.0	0.8	0.2	1.9	1.3	0.0	0.3	2.0	1.1	0.6	0.4	0.0	0.1	2.0	0.6	13.9	15.5	45.2	11.8	11.6	7.6	10.3	5.9	9.1	8.1
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127171-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 184.4"	"Group enriched"	"Detected in some"	7	"CACO-2: 33.3;U-266/70: 55.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"			3400000	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.3	0.2	0.2	17.6	0.3	0.3	0.3	0.2	0.2	0.3	88.9	0.2	0.2	54.5	0.4	0.3	0.4	0.4	7.0	0.6	0.2	0.3	0.3	0.3	0.3	0.5	0.2	0.2	0.3	0.4	0.0	0.3	0.2	0.2	0.4	44.0	0.2	0.3	0.2	0.3	0.2	184.4	1.4	0.2	0.6	0.3	0.3	0.2	0.3	0.2	0.2	0.5	0.4	0.3	1.5	0.8	12.1	1.0	1.4	0.6	0.1	0.1	6.1	0.3	0.4	0.0	0.1	0.5	0.1	0.1	0.0	0.1	33.3	1.5	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.1	0.6	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.4	0.2	0.5	0.2	0.2	0.4	0.1	1.0	0.1	0.1	0.6	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.2	55.3	0.1	0.1	0.1	0.2	0.3	2.5	1.0	1.2	0.5	0.8	0.3	0.6	0.5	0.4	0.8	1.5	0.5	0.6	12.1	1.4	0.5	0.7	0.5	0.1	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27950966-28177446	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.6;parathyroid gland: 35.4"	"Cell line enhanced"	"Detected in many"		"AF22: 56.4;BJ: 40.7;fHDF/TERT166: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.4;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			160000000	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: , HPA058574: "	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	29.6	9.8	1.5	9.4	0.5	0.5	5.7	16.1	3.2	2.0	8.0	0.2	0.8	3.1	1.9	0.6	4.7	1.7	77.6	9.9	9.6	9.2	23.3	0.7	1.1	6.0	9.1	3.4	0.7	35.4	5.4	0.5	5.9	1.4	0.8	6.8	0.5	4.6	0.4	0.5	0.9	3.2	6.7	5.9	2.5	19.6	7.4	0.9	2.8	0.0	1.0	1.0	1.3	0.0	0.0	4.4	0.0	0.7	0.9	0.0	0.0	4.5	56.4	0.0	8.9	1.8	0.0	40.7	12.4	16.6	15.2	0.0	0.0	0.0	21.9	84.2	6.0	9.2	0.0	23.6	0.1	5.9	0.0	15.2	14.0	8.5	0.0	0.0	0.8	0.1	38.1	6.7	14.5	0.0	0.0	12.9	0.0	10.2	0.0	7.5	4.9	0.0	6.7	7.7	0.0	1.8	14.7	25.5	0.0	0.0	4.5	0.0	0.0	2.2	36.0	11.5	0.5	29.4	0.0	0.0	0.0	6.9	0.0	27.7	4.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	9.8	9.4	5.7	10.1	9.9	9.6	6.0	9.1	5.9	7.4
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell line enhanced"	"Detected in some"		"A-431: 24.4;HaCaT: 67.7;HBEC3-KT: 32.6;hTCEpi: 26.1;hTERT-HME1: 19.9;RPTEC TERT1: 29.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.4	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.6	9.1	0.0	0.1	0.0	67.7	0.6	32.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.1	0.0	19.9	0.0	0.0	0.0	0.0	12.7	0.0	0.0	1.2	2.0	0.0	0.0	0.0	29.3	11.0	0.1	0.0	0.2	0.0	11.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"				Centrosome	"Cell Junctions"	"CAB079753: , HPA035820: AB_10671939, HPA046529: "	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.8	23.3	14.0	10.1	14.9	12.5	12.3	9.5	14.0	13.1	13.2	12.6	17.8	5.7	12.0	21.0	18.4	14.1	13.5	14.2	7.4	15.2	30.8	23.3	9.5	18.7	10.2	26.8	9.4	12.4	16.4	12.1	14.0	15.5	18.3	21.5	20.0	12.0	21.6	12.7	19.7	27.9	8.4	10.0	7.6	15.3	17.6	21.4	11.8	14.2	27.6	12.9	8.1	12.2	13.3	14.2	13.9	11.3	15.7	20.0	12.7	12.0	25.5	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407983-87464465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 17.7;testis: 60.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.4;RPTEC TERT1: 5.3;T-47d: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA044891: AB_10960832, HPA072261: "	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.2	0.5	1.3	0.3	3.0	0.2	0.5	0.3	2.2	0.9	0.3	3.0	0.2	0.3	0.7	3.4	0.2	17.7	0.4	0.3	2.1	2.0	1.5	0.3	2.4	0.2	0.7	1.4	2.7	0.3	0.8	2.6	0.4	8.1	0.5	0.2	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.5	0.2	0.2	60.5	0.6	0.0	1.4	0.0	0.2	0.4	0.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.9	0.5	2.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.2	1.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.9	0.0	0.2	0.0	0.1	0.8	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	1.2	1.1	0.6	0.4	0.5	0.3	9.0	0.2	0.0	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.3	3.0	0.3	2.2	2.1	2.0	0.7	1.4	8.1	0.6
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.0;CACO-2: 37.3;CAPAN-2: 24.6;RT4: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			24000000	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favourable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	3.9	0.3	2.1	8.5	5.1	0.0	4.1	11.9	3.5	2.2	18.0	3.7	15.5	23.9	1.0	3.5	5.9	6.1	11.9	0.5	1.4	1.4	10.7	15.0	12.4	0.2	5.0	1.0	1.4	25.3	22.1	4.7	1.9	4.8	4.6	11.6	1.8	19.8	14.4	0.2	11.6	44.1	1.8	1.9	0.2	13.6	6.4	4.3	0.9	3.6	2.3	4.3	6.9	3.8	1.2	0.9	2.6	1.0	1.6	2.4	0.1	11.7	1.3	1.1	1.9	0.0	0.0	15.0	0.0	0.0	0.3	0.4	37.3	24.6	0.5	4.0	0.0	11.2	3.6	2.1	0.2	7.0	2.5	1.0	0.5	0.8	0.0	0.2	1.6	0.0	0.4	0.5	0.3	0.1	0.5	3.6	0.0	10.8	2.0	0.2	9.6	1.0	2.2	1.2	1.7	7.9	18.1	3.8	1.9	0.7	11.4	0.4	14.1	0.1	0.2	0.1	3.6	0.2	0.5	3.3	3.3	2.1	0.1	1.3	0.9	1.1	1.0	0.4	2.4	0.4	0.7	0.7	0.7	0.5	0.1	1.2	0.8	1.4	2.6	1.6	0.5	0.9	0.7	0.1	2.1	5.1	11.9	3.5	1.4	1.4	5.0	1.0	4.8	4.3
CGNL1	"FLJ14957, JACOP, KIAA1749, PCING"	ENSG00000128849	"Cingulin like 1"	Q0VF96	15	57375967-57550727	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.8;HUVEC TERT2: 31.0;TIME: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013500, HPA056911, HPA069214"	Enhanced		Supported	"Nuclear bodies,Cell Junctions"				"Cell Junctions"	"Nuclear bodies"	"CAB013500: , HPA056911: , HPA069214: "	"unprognostic (1.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.52e-2)"	"prognostic favourable (3.55e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.51e-3)"	"prognostic favourable (5.58e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (1.37e-6)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.18e-2)"	3.1	8.7	10.8	1.7	9.8	0.6	14.6	3.2	12.2	25.7	2.0	7.3	8.9	1.4	14.9	4.9	7.7	7.0	2.7	13.6	11.2	7.8	54.8	26.2	15.3	1.3	8.3	5.9	8.1	13.6	12.5	2.9	20.8	10.9	27.6	2.3	11.1	32.0	12.7	1.0	7.4	1.7	10.6	5.3	0.8	9.0	5.2	9.7	1.3	15.0	4.2	8.0	10.0	14.6	0.5	0.2	1.1	0.1	0.3	0.2	0.0	0.0	0.7	7.8	0.0	0.0	0.0	0.1	0.1	1.7	0.6	1.4	4.8	0.0	0.0	6.9	1.0	0.0	3.7	0.0	1.0	0.0	0.6	0.0	0.1	3.3	0.1	0.0	0.0	0.3	0.2	0.8	0.0	31.0	0.0	0.0	1.2	1.3	0.0	0.1	3.8	0.3	0.0	3.9	0.1	2.6	0.0	0.2	0.4	0.0	3.0	0.0	0.3	0.3	18.9	0.0	2.0	0.0	1.0	0.0	0.0	0.0	0.1	3.5	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.2	1.1	0.3	0.0	0.2	0.1	0.0	10.8	9.8	3.2	12.2	11.2	7.8	8.3	5.9	10.9	9.7
CHCHD7	"COX23, MGC2217"	ENSG00000170791	"Coiled-coil-helix-coiled-coil-helix domain containing 7"	Q9BUK0	8	56211686-56218798	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050783	Approved		Approved	"Cell Junctions,Aggresome"				"Cell Junctions"	Aggresome	"HPA050783: "	"unprognostic (1.64e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavourable (1.39e-6)"	"unprognostic (4.46e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.04e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (9.47e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.50e-1)"	16.6	14.8	24.1	19.6	29.4	17.6	18.9	27.1	23.3	17.6	20.7	18.3	22.8	22.5	13.1	34.3	15.7	17.6	12.3	27.0	21.0	19.5	23.4	18.0	19.4	24.4	27.0	16.0	36.3	20.0	22.5	48.3	13.3	26.7	19.2	21.3	19.2	34.5	18.0	23.2	14.6	26.2	14.8	32.0	33.0	17.7	7.6	24.8	27.4	19.8	18.3	24.9	15.5	16.4	31.0	33.6	26.2	20.6	24.2	31.1	17.3	18.8	6.0	13.5	4.4	36.0	25.6	14.0	13.5	12.7	10.8	8.1	15.4	23.1	17.8	11.9	7.9	10.6	14.0	20.7	13.4	7.7	26.9	27.2	14.4	21.3	18.3	23.2	17.5	30.5	19.1	7.6	34.2	11.2	13.3	11.7	25.3	9.4	23.1	34.4	11.9	8.7	26.6	4.1	14.8	19.8	20.4	3.5	2.3	7.1	11.0	10.0	11.5	13.0	16.2	5.7	12.1	18.3	12.6	12.4	12.6	29.7	16.0	34.5	9.7	21.5	20.6	26.2	23.2	19.0	22.5	31.0	26.0	23.6	22.8	26.4	31.1	27.8	7.9	24.2	16.6	33.6	29.7	17.3	24.1	29.4	27.1	23.3	21.0	19.5	27.0	16.0	26.7	24.8
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624119-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7"	"Group enriched"	"Detected in some"	16	"SCLC-21H: 20.2;SH-SY5Y: 26.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6"	"Not detected"	"Not detected"			HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"				"Endoplasmic reticulum"	"Cell Junctions"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.2	6.6	2.7	3.9	0.8	0.7	0.2	0.5	0.4	0.6	2.3	0.2	0.0	0.2	0.8	0.7	1.4	0.1	0.1	0.8	1.0	0.3	0.5	0.1	0.1	2.9	0.2	0.0	0.3	0.2	0.0	1.6	0.0	1.3	0.2	1.1	10.6	2.2	2.4	0.6	0.3	1.0	0.9	1.0	1.0	0.8	10.7	0.1	18.5	0.4	0.3	1.1	0.5	0.5	1.5	0.4	1.4	0.8	1.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.2	26.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.3	0.5	0.2	0.6	0.9	0.5	0.6	0.2	1.5	0.8	0.8	1.4	1.0	0.4	0.4	0.3	0.0	2.7	0.8	0.5	0.4	1.0	0.3	0.2	0.0	1.3	0.1
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418865-170454733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;ovary: 47.7;testis: 86.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 56.4;ASC TERT1: 71.2;EFO-21: 42.2;HUVEC TERT2: 60.9;TIME: 96.3"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"				"Cell Junctions"	"Lipid droplets"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favourable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	8.2	1.9	14.1	2.0	40.6	1.7	6.3	3.5	50.3	1.9	3.4	85.9	0.5	2.2	2.7	4.6	4.6	4.2	18.9	4.0	28.7	13.0	3.2	2.8	2.8	2.1	59.5	17.1	47.7	2.1	1.8	5.5	4.2	37.3	5.1	2.5	0.6	4.7	4.2	1.7	3.6	2.6	2.8	80.6	2.6	2.5	86.1	47.9	0.0	2.0	0.9	2.0	6.3	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	56.4	71.2	0.0	0.7	3.6	4.6	7.7	0.0	9.4	0.0	42.2	5.7	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	3.2	17.4	0.0	0.0	26.0	0.0	25.3	0.0	60.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	96.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.1	40.6	3.5	25.0	28.7	13.0	59.5	17.1	37.3	47.9
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Group enriched"	"Detected in some"	20	"A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: "	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 166.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.6;CACO-2: 27.7;CAPAN-2: 53.9;HaCaT: 113.3;MCF7: 39.4;SK-BR-3: 47.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favourable (8.96e-11)"	"prognostic favourable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (1.62e-1)"	1.6	2.0	0.4	28.0	0.4	0.0	9.5	0.4	0.4	9.9	71.4	0.4	47.6	47.2	2.4	49.3	73.4	13.4	47.2	0.7	0.4	0.3	30.0	12.1	32.3	0.8	0.4	0.4	3.4	70.9	12.3	7.3	25.0	0.4	9.8	42.5	0.7	40.9	42.2	0.9	2.9	166.7	1.8	0.5	1.4	1.2	1.8	0.4	1.5	40.5	28.3	45.6	12.2	19.3	3.8	1.6	0.0	3.0	2.2	6.7	2.3	3.2	0.3	0.0	0.0	0.0	0.2	26.6	0.0	0.0	0.0	0.0	27.7	53.9	0.0	1.0	0.1	113.3	0.0	3.4	0.0	0.0	0.6	0.0	0.7	0.0	2.1	0.0	0.2	0.5	5.4	0.0	0.2	2.5	0.3	0.1	0.0	39.4	0.0	0.3	0.1	1.0	0.0	0.0	0.7	0.0	0.0	6.5	0.1	0.3	47.2	0.0	17.2	0.4	5.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	2.2	3.0	4.8	0.5	1.5	3.3	1.6	3.8	3.7	6.7	0.0	2.2	0.1	0.2	0.9	2.3	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012456-3014505	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.5;MCF7: 19.1;SCLC-21H: 15.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076613			Supported	"Vesicles,Cell Junctions"				"Cell Junctions"	Vesicles	"HPA076613: "	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.4	0.4	0.5	2.1	5.2	0.3	16.5	1.4	0.6	1.0	0.3	0.3	1.8	0.3	0.9	0.3	2.3	1.1	0.4	0.8	0.8	0.6	2.6	1.5	0.3	1.4	0.3	0.3	9.6	4.8	15.9	10.2	0.5	0.3	0.1	0.3	1.7	0.3	1.5	0.4	1.2	0.3	2.2	1.0	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	5.5	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	19.1	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.2	0.1	15.0	0.1	0.7	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.1	16.5	1.4	0.8	0.8	1.4	0.3	0.5	0.3
CMTR2	"AFT, FLJ11171, FTSJD1, MTr2"	ENSG00000180917	"Cap methyltransferase 2"	Q8IYT2	16	71281389-71289715	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041700, HPA048265"	Uncertain		Approved	"Nuclear speckles,Cell Junctions"				"Cell Junctions"	"Nuclear speckles"	"HPA041700: , HPA048265: "	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.86e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.39e-2)"	"prognostic favourable (4.97e-5)"	"unprognostic (9.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.34e-2)"	10.4	14.9	7.1	11.7	9.0	5.4	15.9	5.3	9.1	10.6	13.4	11.5	15.6	14.1	12.5	16.4	20.4	8.8	11.0	9.0	8.5	6.9	13.5	18.2	10.7	14.7	12.4	3.4	16.2	12.2	12.7	24.3	17.4	9.0	11.9	10.5	10.6	13.6	14.1	8.4	9.9	16.1	9.4	9.5	17.5	8.9	16.0	9.3	20.9	14.3	7.6	15.4	9.6	14.2	11.2	10.3	11.0	8.0	13.1	11.2	8.6	11.3	7.9	11.4	11.3	12.9	11.2	6.4	9.3	9.1	10.5	10.1	4.7	15.8	6.1	11.2	7.3	11.2	7.0	8.3	12.9	6.3	4.7	17.0	4.6	5.9	16.1	10.0	23.3	8.1	15.9	7.7	10.4	11.9	7.3	4.6	17.4	10.1	12.1	16.9	7.1	4.7	16.4	7.3	13.2	12.9	7.7	7.5	8.5	10.5	9.2	10.2	13.7	7.3	11.4	11.9	11.0	12.1	7.2	8.6	8.9	10.9	8.9	10.2	10.2	11.0	7.2	7.1	9.8	8.0	11.2	11.2	9.2	10.3	10.3	10.2	10.5	10.3	0.4	13.1	5.2	3.6	8.0	8.6	7.1	9.0	5.3	9.1	8.5	6.9	12.4	3.4	9.0	9.3
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.9;HeLa: 28.3;RPMI-8226: 21.8;SK-BR-3: 12.7;U-266/84: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Low region specificity"	"Detected in many"							"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favourable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	1.8	1.3	27.5	1.8	26.1	0.7	9.5	12.5	23.8	3.9	11.6	27.9	2.2	11.6	2.0	4.4	9.5	12.7	5.8	32.8	27.7	14.5	8.3	12.3	8.8	0.7	23.8	13.8	2.6	11.4	24.7	5.2	3.4	10.8	9.4	7.3	2.8	26.9	3.7	68.7	10.7	20.7	2.2	25.0	0.8	7.4	2.5	16.8	0.0	5.5	12.2	3.1	1.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	5.8	4.3	0.0	0.1	0.0	0.0	15.9	0.0	0.0	0.0	0.0	10.4	9.4	0.0	0.4	0.0	10.9	6.0	0.0	0.0	0.0	4.6	0.0	28.3	2.2	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	3.0	0.1	0.0	3.6	0.0	0.0	4.2	3.6	0.0	0.2	21.8	8.5	0.0	5.7	0.1	2.0	12.7	1.8	9.1	0.0	0.0	0.0	5.2	0.1	0.4	0.0	16.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	27.5	26.1	12.5	19.0	27.7	14.5	23.8	13.8	10.8	16.8
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Neurotransmitter degradation"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Group enriched"	"Detected in some"	5	"BEWO: 16.9;HDLM-2: 5.5;U-937: 8.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"			"Plasma membrane"	"Cell Junctions"	"HPA045876: "	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.1	1.4	1.0	16.9	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.2	0.2	0.3	0.4	0.5	5.5	1.2	0.6	0.7	0.1	0.2	0.4	1.1	0.8	0.4	0.8	0.3	0.3	0.0	0.5	0.8	0.3	0.6	1.8	0.2	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.7	0.2	0.1	0.4	1.2	0.8	0.1	0.1	1.0	1.8	0.6	1.6	1.5	0.1	0.1	8.5	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"			5400	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: , HPA063535: "	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favourable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	55.9	54.0	39.6	24.4	50.2	10.9	55.1	16.5	39.5	43.4	58.9	68.5	33.9	44.2	53.0	47.5	76.9	45.8	41.1	68.6	38.8	32.3	62.2	37.7	49.8	27.0	57.3	29.3	42.7	38.1	55.5	25.6	54.0	45.5	39.4	49.0	35.6	48.8	43.5	30.5	49.8	53.9	59.6	49.7	30.9	48.2	18.7	56.6	8.1	51.2	46.4	44.1	48.4	45.1	3.8	15.2	9.8	21.8	0.3	5.0	7.1	32.5	23.8	36.0	53.3	31.4	34.5	54.9	33.0	41.6	31.6	40.1	49.5	44.3	0.1	28.0	49.2	25.0	24.7	54.3	36.8	18.7	21.5	13.7	39.1	30.0	37.9	0.2	13.4	21.7	43.5	37.7	41.5	59.5	7.5	14.2	34.0	28.8	0.3	4.2	14.5	0.5	12.9	21.0	19.6	66.7	43.6	14.4	19.0	60.9	85.7	49.8	30.3	9.4	50.4	33.3	18.0	20.6	22.8	5.1	9.6	1.9	31.7	5.9	42.9	2.2	17.1	1.5	2.9	21.8	1.9	3.8	2.1	2.1	15.2	3.2	0.1	1.1	9.8	0.3	20.2	3.7	5.0	7.1	39.6	50.2	16.5	39.5	38.8	32.3	57.3	29.3	45.5	56.6
CXADR	CAR	ENSG00000154639	"CXADR, Ig-like cell adhesion molecule"	P78310	21	17512382-17593579	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 31.7;Hep G2: 20.5;NTERA-2: 36.7;RT4: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"		11000	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	4.0	3.1	6.4	3.2	9.4	1.3	5.8	2.0	15.4	6.3	27.1	12.5	9.0	24.9	3.3	9.3	15.0	6.5	17.2	10.8	7.9	5.5	5.1	28.6	9.9	4.2	9.2	5.6	1.1	12.0	5.2	11.1	0.3	11.6	9.2	15.4	3.7	16.3	15.8	0.6	30.0	41.4	2.1	13.0	1.4	17.6	8.5	6.9	0.9	13.1	4.9	3.8	14.7	10.0	0.8	0.4	2.6	0.5	0.9	2.7	0.9	5.5	3.1	15.2	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.9	31.7	4.9	2.0	6.8	0.0	9.6	7.6	2.0	0.3	3.1	6.5	0.0	9.1	20.5	0.9	0.6	0.0	0.0	8.3	0.4	0.1	3.0	0.1	0.1	0.0	0.3	1.2	0.0	36.7	0.0	0.0	5.1	3.9	12.7	35.4	6.1	4.1	3.6	4.1	2.1	8.4	0.1	0.1	0.0	9.1	0.1	2.2	1.5	2.5	0.1	1.2	0.0	0.2	2.6	0.5	0.4	0.5	0.2	1.0	0.3	2.6	0.6	0.1	0.8	2.7	0.8	1.4	0.9	0.2	0.4	0.5	0.9	6.4	9.4	2.0	15.4	7.9	5.5	9.2	5.6	11.6	6.9
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: "	"prognostic favourable (7.29e-4)"	"prognostic favourable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	12.2	22.2	5.3	13.3	8.6	8.1	11.3	11.0	8.2	16.8	13.5	7.3	13.4	6.0	18.2	14.1	25.4	14.3	13.0	6.1	4.7	2.9	6.6	20.8	11.3	16.1	15.0	5.0	9.8	15.6	6.1	8.6	5.5	6.3	20.9	12.3	8.1	17.6	14.8	6.3	36.9	11.0	19.0	17.6	15.1	9.1	7.6	7.6	23.3	6.6	16.7	26.0	17.3	15.2	11.4	6.1	11.5	11.0	7.4	27.0	9.0	8.2	22.3	9.3	7.0	6.0	12.2	11.0	9.1	21.3	11.6	13.7	3.6	4.8	19.9	1.9	8.3	14.6	5.3	18.5	5.8	4.9	10.0	4.7	21.3	16.5	5.9	5.4	12.4	16.3	21.0	5.8	13.0	34.0	1.2	9.7	19.0	15.6	20.7	2.6	3.0	8.1	10.4	2.3	10.7	4.9	8.2	4.9	6.1	11.1	3.2	2.9	20.4	1.8	14.6	35.7	16.3	7.8	4.2	10.2	7.7	4.4	13.4	6.9	12.8	5.9	8.1	11.5	12.1	11.0	11.7	11.4	12.7	11.7	6.1	7.4	9.4	10.1	2.2	7.4	9.2	0.1	27.0	9.0	5.3	8.6	11.0	8.2	4.7	2.9	15.0	5.0	6.3	7.6
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.2;HBEC3-KT: 24.0;RT4: 31.9;T-47d: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"		2100000	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favourable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	6.7	11.3	23.5	7.9	36.2	2.2	12.5	6.8	42.2	9.7	25.2	57.4	17.6	16.8	7.7	10.5	30.5	31.7	18.9	8.7	27.8	20.8	19.8	3.5	13.2	3.1	55.7	19.8	11.3	20.9	28.2	14.6	13.3	34.7	17.7	14.9	4.0	28.3	20.5	9.1	41.3	32.1	3.1	43.2	5.1	52.2	5.1	37.0	8.7	20.9	10.5	7.6	16.3	16.6	1.8	0.4	0.0	0.2	0.0	1.8	0.9	19.3	6.4	9.1	1.9	0.6	0.8	5.6	0.5	0.1	0.2	0.0	8.6	10.3	0.1	10.8	1.7	31.2	1.9	24.0	0.1	10.7	3.4	0.0	5.8	2.2	1.8	0.0	0.4	1.2	12.4	0.1	0.2	0.7	5.6	0.2	1.3	12.2	0.6	0.0	1.5	1.3	1.3	6.8	0.7	4.6	31.9	1.6	0.8	1.8	14.4	7.0	35.8	0.2	1.4	4.5	4.2	0.4	4.5	0.2	0.0	0.8	2.9	0.0	3.9	0.0	0.2	0.0	1.1	0.0	0.8	0.4	0.2	0.7	0.4	1.8	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.9	23.5	36.2	6.8	25.0	27.8	20.8	55.7	19.8	34.7	37.0
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;Hep G2: 19.9;HHSteC: 9.0;U-937: 28.3"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"		270000	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	19.9	9.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030110-2043430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA069750: , HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	16.6	22.9	17.6	19.0	22.7	10.3	17.0	38.6	26.5	17.8	17.1	17.2	21.1	17.0	22.2	17.0	17.9	29.0	22.6	20.2	14.1	13.1	21.4	32.7	15.7	22.7	17.0	21.6	25.2	29.4	28.4	42.9	17.3	15.4	26.1	13.3	21.3	25.7	23.9	33.3	29.0	17.3	18.9	11.4	17.8	18.4	19.5	19.9	17.5	21.0	25.8	19.0	17.2	16.0	11.3	9.3	0.7	6.8	5.6	12.0	5.5	9.0	15.8	4.3	10.6	13.6	9.9	11.9	11.9	17.9	20.3	13.2	15.1	7.4	17.6	15.4	35.2	7.2	14.5	13.4	11.0	4.6	33.3	4.1	7.4	9.0	12.9	5.1	6.7	14.9	13.7	16.2	13.2	9.1	13.8	7.2	7.9	11.9	9.0	3.3	4.0	16.2	10.4	3.1	13.6	9.0	5.6	8.2	9.5	10.8	12.2	11.9	17.8	4.2	6.3	14.2	6.5	17.4	10.7	7.2	5.0	4.3	13.9	7.0	4.9	0.0	4.6	0.7	9.5	6.8	10.4	11.3	7.8	8.6	9.3	9.5	12.0	8.7	0.3	5.6	4.6	6.7	10.4	5.5	17.6	22.7	38.6	26.5	14.1	13.1	17.0	21.6	15.4	19.9
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Not detected"	"Not detected"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"			2700000	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: , HPA073937: "	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.4	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.4	0.0	16.0	0.0	0.0	3.8	0.2	1.3	0.1	2.6	0.0	0.0	2.7	41.1	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.7	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
EFCAB11	C14orf143	ENSG00000140025	"EF-hand calcium binding domain 11"	Q9BUY7	14	89794669-89954777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051209			Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA051209: "	"unprognostic (1.03e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.84e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.45e-2)"	4.7	5.8	10.2	6.2	8.1	5.3	9.3	5.7	7.6	5.6	5.2	10.4	6.7	5.1	4.9	6.9	6.2	11.0	4.9	3.7	7.8	6.6	7.6	5.8	3.2	3.3	8.6	5.7	5.2	4.8	8.3	8.2	8.4	7.7	5.4	5.6	6.1	5.6	5.4	2.4	3.7	3.6	6.3	8.4	6.7	4.4	36.9	6.2	2.5	7.9	3.3	6.3	5.2	4.1	2.6	2.1	12.8	5.3	3.3	1.6	0.8	4.9	7.6	6.6	8.2	4.1	4.4	18.7	7.2	6.6	9.9	6.9	8.9	17.5	7.7	13.8	4.8	10.8	5.7	14.4	14.3	8.6	3.6	5.5	6.5	14.5	0.9	7.0	13.4	3.0	3.6	6.4	7.4	8.2	5.8	7.6	11.7	25.5	5.2	9.5	2.8	13.7	6.0	10.5	5.5	9.1	13.7	2.8	4.7	9.1	17.0	8.5	13.8	5.1	6.9	5.4	7.4	5.6	7.0	4.6	13.1	13.3	7.8	3.3	9.7	12.8	1.3	3.4	0.6	3.0	0.3	2.6	1.0	1.0	2.1	2.6	1.6	1.4	4.0	3.3	5.3	1.8	1.3	0.8	10.2	8.1	5.7	7.6	7.8	6.6	8.6	5.7	7.7	6.2
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell line enriched"	"Detected in many"	12	"A-431: 337.7"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"		93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: , CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavourable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	337.7	4.3	1.1	1.5	6.9	4.3	1.1	3.3	4.5	2.0	1.6	0.8	3.7	0.2	0.8	2.8	13.5	0.0	14.9	2.5	0.1	0.2	0.0	1.8	0.2	1.8	0.0	0.0	2.1	13.7	5.2	27.9	0.2	0.0	0.0	4.4	0.2	0.0	0.0	0.3	2.2	0.0	0.6	0.0	2.5	3.6	0.0	1.3	2.8	3.4	0.6	0.3	0.7	1.0	1.9	0.5	14.6	3.1	0.0	0.3	0.1	2.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 13.3"	"Cell line enhanced"	"Detected in some"		"REH: 19.1;U-138 MG: 12.0;U-2 OS: 17.6;U-2197: 20.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"			11000	"Nucleoplasm, Cell Junctions"		"HPA066382: "	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	1.8	0.8	2.2	0.6	1.4	0.0	0.6	0.0	4.2	3.2	0.3			0.2	2.2	0.3	0.3	0.8	0.8	3.3	1.8	2.2	2.8	13.3	0.3	0.1	2.7		0.0	0.2	0.2	0.2	0.7		0.6	0.0		0.5	0.2	1.2	0.6	0.3	0.5	1.7	1.7	0.2	0.7			0.2		0.0	0.5	0.9	0.5	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	2.9	6.2	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.1	0.3	0.0	3.0	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.5	0.0	2.8	1.2	0.7	19.1	0.0	1.9	0.0	0.0	2.8	1.3	0.1	0.1	0.0	0.0	0.2	0.0	12.0	17.6	20.5	0.0	0.0	0.2	5.1	0.0	0.0	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.0										
ELMO3	"CED-12, CED12, ELMO-3, FLJ13824"	ENSG00000102890	"Engulfment and cell motility 3"	Q96BJ8	16	67199111-67204029	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;CAPAN-2: 24.5;HaCaT: 23.2;T-47d: 22.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA021484	Approved		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA021484: AB_1848129"	"unprognostic (4.49e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.14e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.95e-3)"	"prognostic favourable (2.77e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-2)"	1.1	0.8	0.6	7.8	1.8	2.5	4.6	6.7	1.4	2.8	30.3	0.5	32.0	18.9	2.6	9.8	13.1	4.8	16.0	0.9	0.7	0.8	13.3	3.9	6.9	1.4	0.5	0.5	1.2	26.6	6.5	28.7	13.7	1.0	13.2	5.1	0.9	25.1	28.8	0.5	19.1	37.7	1.7	0.5	2.8	12.8	8.7	0.6	1.1	18.2	9.7	9.2	6.8	6.0	1.2	0.8	2.1	0.4	0.4	1.0	0.1	10.6	1.2	1.2	1.5	0.2	0.3	16.7	0.6	0.3	0.8	0.7	7.0	24.5	1.5	0.8	0.3	23.2	1.1	10.7	0.1	0.7	1.4	1.5	1.9	2.3	0.5	0.9	3.8	0.2	7.9	0.6	0.6	0.8	1.4	0.7	0.4	8.9	0.9	4.5	1.6	0.9	2.2	1.1	2.3	1.0	1.4	8.2	1.8	1.5	7.3	0.7	22.9	1.6	1.4	1.9	2.3	1.1	1.1	2.5	0.8	2.8	0.9	2.1	0.9	0.0	0.4	1.0	1.0	0.0	0.1	1.2	0.8	0.1	0.5	1.1	0.6	0.2	2.1	0.4	0.1	0.8	0.5	0.1	0.6	1.8	6.7	1.4	0.7	0.8	0.5	0.5	1.0	0.6
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.6;ASC TERT1: 20.5;HUVEC TERT2: 18.5;SCLC-21H: 20.7;TIME: 50.8;U-2 OS: 18.5;U-2197: 18.0;U-251 MG: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 11.6"	"Lineage enriched"	"Detected in many"	4	"monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"			140000	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	17.1	19.4	12.0	16.4	32.1	2.5	8.9	35.9	36.3	5.1	10.6	36.2	1.4	29.8	5.8	7.1	6.8	8.8	6.0	6.0	11.3	16.6	21.0	3.1	8.8	8.8	46.4	15.9	7.8	4.4	14.7	9.0	12.7	46.8	4.0	8.4	3.8	3.6	5.0	4.6	3.5	27.9	8.3	27.2	10.5	3.2	35.9	36.6	0.9	4.0	1.5	2.6	5.6	5.8	0.0	2.5	0.7	11.6	0.0	0.6	0.7	0.0	0.3	1.2	0.0	17.6	20.5	13.8	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	12.0	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	1.4	10.7	0.0	3.8	0.0	18.5	0.1	0.1	0.0	0.0	0.1	0.2	2.5	3.9	0.0	0.0	0.0	0.1	1.4	20.7	0.1	0.0	0.1	8.2	0.2	1.4	50.8	0.1	18.5	18.0	21.8	0.0	0.0	0.0	0.0	1.6	2.1	0.0	4.5	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.6	0.0	0.7	0.0	11.6	0.0	0.0	0.7	12.0	32.1	35.9	27.7	11.3	16.6	46.4	15.9	46.8	36.6
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318625-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 106.7"	"Cell line enriched"	"Detected in some"	6	"HAP1: 20.8"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 2.2;glioma: 9.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favourable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	1.6	1.4	29.1	2.9	50.5	9.7	1.6	2.7	106.7	1.4	1.8	52.4	0.0	1.8	1.6	1.5	1.7	1.4	1.9	1.6	40.9	21.4	1.5	1.5	2.0	3.1	75.1	18.4	1.5	1.6	1.4	0.1	1.4	54.5	1.5	1.9	4.3	2.4	1.5	1.7	1.9	1.9	1.6	100.9	2.5	2.2	1.7	69.5	0.0	1.6	0.0	2.7	1.7	0.1	1.7	1.3	3.9	1.6	2.4	2.1	0.7	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.2	0.0	1.9	0.3	20.8	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.2	2.8	0.4	0.2	0.7	2.3	0.3	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.6	0.0	0.1	0.0	0.7	1.2	0.0	0.2	0.1	0.2	0.6	3.4	1.9	0.5	1.8	0.9	1.0	2.6	1.6	1.1	2.1	1.2	1.0	0.7	0.8	0.6	0.6	1.7	1.5	1.6	3.9	2.4	1.0	1.3	0.9	0.7	29.1	50.5	2.7	27.9	40.9	21.4	75.1	18.4	54.5	69.5
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021348	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;HaCaT: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 44.5;neutrophil: 32.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"			41000000	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: "	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	20.7	13.3	3.0	9.6	3.6	6.4	11.8	2.0	3.5	14.5	36.3	3.9	21.4	20.5	8.6	11.2	41.5	12.3	30.5	10.0	3.4	3.2	35.9	69.8	55.0	10.4	3.6	1.8	10.9	37.9	18.5	16.3	61.8	5.3	17.8	19.5	5.7	59.3	23.7	9.0	22.0	59.8	4.9	4.0	27.0	18.8	11.0	3.3	8.1	52.2	25.8	29.9	16.8	19.7	1.3	7.0	44.5	8.9	2.2	3.8	6.6	28.5	3.7	1.1	0.3	0.8	0.0	23.3	0.1	0.0	1.0	1.0	26.4	37.7	2.1	19.4	0.0	49.4	5.8	24.5	1.5	1.6	4.3	6.0	1.5	12.0	1.1	5.6	17.8	0.3	31.0	0.1	8.2	23.2	8.1	0.6	0.1	12.3	1.7	3.2	19.7	5.3	2.6	0.0	9.2	16.6	21.7	8.2	2.1	6.9	29.7	6.1	32.3	10.0	13.9	0.1	0.7	0.1	0.2	6.9	13.6	0.7	4.4	5.5	1.8	7.6	8.9	44.5	3.8	4.5	2.0	1.3	3.5	2.3	7.0	0.9	3.4	2.7	32.2	2.2	3.4	5.3	1.5	6.6	3.0	3.6	2.0	3.5	3.4	3.2	3.6	1.8	5.3	3.3
FAM126B	"HYCC2, MGC39518"	ENSG00000155744	"Family with sequence similarity 126 member B"	Q8IXS8	2	200973718-201071671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036166, HPA036167, HPA067307"	Uncertain		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA036166: AB_10696651, HPA036167: , HPA067307: "	"unprognostic (7.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.52e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	10.5	6.9	9.8	8.7	17.2	22.1	7.3	28.7	21.1	5.9	10.3	6.5	5.9	9.8	6.8	6.3	12.1	5.8	6.4	6.5	9.3	9.2	12.0	10.9	9.4	7.9	7.3	11.6	7.8	7.1	9.8	16.6	7.2	15.1	5.8	9.6	8.8	7.0	4.9	5.6	10.2	9.3	5.8	8.1	10.6	11.0	6.3	6.4	8.3	10.3	2.9	8.7	5.5	8.1	2.1	1.2	20.3	1.9	2.3	3.4	1.5	3.2	1.7	2.5	2.6	2.6	3.5	5.4	3.1	1.8	2.5	2.4	4.4	3.9	3.0	3.1	3.1	4.0	5.0	1.9	3.9	4.3	3.1	8.7	4.6	4.1	2.1	10.5	7.6	1.5	2.4	3.4	2.1	2.4	8.0	11.2	2.5	2.0	6.3	6.9	1.7	2.9	3.7	3.7	2.7	2.4	3.6	4.9	2.5	3.3	3.8	2.8	2.6	4.6	4.8	4.7	3.4	2.3	2.8	8.3	34.6	6.4	2.8	4.1	3.2	1.7	1.4	5.1	3.1	1.8	3.4	2.1	2.6	2.4	1.2	2.0	2.6	3.1	20.3	2.3	1.9	0.9	1.7	1.5	9.8	17.2	28.7	21.1	9.3	9.2	7.3	11.6	15.1	6.4
FBLN7	"FLJ37440, TM14"	ENSG00000144152	"Fibulin 7"	Q53RD9	2	112138385-112188216	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 17.4;BJ hTERT+: 12.4;SCLC-21H: 11.2;SH-SY5Y: 9.0;U-2197: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4"	"Lineage enriched"	"Detected in single"	36	"T-cells: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034992			Approved	"Plasma membrane,Cell Junctions"	"Secreted to extracellular matrix"		27000	"Plasma membrane"	"Cell Junctions"	"HPA034992: AB_10601469"	"unprognostic (1.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.33e-2)"	7.5	5.8	2.9	9.0	3.4	1.1	10.4	10.3	16.4	12.4	2.3	1.6	4.1	1.7	6.5	8.2	2.9	10.5	7.1	3.3	4.0	3.8	2.5	6.6	3.7	11.8	6.9	4.2	2.8	3.4	16.7	27.4	13.6	10.5	4.7	2.0	14.7	3.9	9.0	1.9	7.1	3.8	3.2	2.2	7.3	4.1	2.0	1.1	8.7	14.9	5.5	9.5	3.6	10.4	0.0	0.5	0.0	0.0	0.0	18.5	3.5	0.0	0.1	17.4	0.0	1.9	1.4	0.0	3.8	12.4	4.2	6.6	0.0	0.1	0.0	0.1	5.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.3	0.8	0.9	0.0	0.0	1.3	0.1	7.0	0.0	1.0	0.0	0.0	1.4	0.0	0.4	0.0	0.4	0.3	0.0	0.0	4.4	0.2	0.0	11.2	9.0	0.0	0.0	0.5	0.4	0.1	3.6	0.6	0.5	18.0	0.5	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	18.5	0.2	0.0	0.0	16.2	0.5	0.0	0.0	0.0	0.5	17.4	3.5	2.9	3.4	10.3	16.4	4.0	3.8	6.9	4.2	10.5	1.1
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;PC-3: 15.1;SCLC-21H: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: "		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favourable (6.28e-4)"	"prognostic favourable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.5"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	15.1	10.7	15.2	5.3	13.4	5.4	7.6	10.5	19.8	4.5	5.6	6.8	40.5	17.9	5.1	8.4	8.6	4.6	4.3	7.0	12.9	8.1	6.0	6.6	7.5	2.2	11.3	10.2	2.9	10.0	4.6	6.8	4.3	9.5	7.1	2.2	3.2	12.7	22.9	4.9	22.4	13.0	4.5	10.0	11.5	8.3	16.6	8.8	0.0	4.5	9.2	3.5	3.9	4.7	0.0	1.1	3.1	2.0	0.0	0.2	1.2	8.2	9.6	1.5	6.1	2.4	2.3	9.6	12.3	3.8	5.2	2.7	4.3	5.9	0.0	5.6	6.5	25.1	2.5	7.0	0.9	11.2	1.2	10.8	7.6	3.0	3.0	0.1	7.6	2.4	4.8	5.0	2.0	6.9	5.1	1.7	3.7	7.0	0.2	6.0	2.2	21.7	0.2	4.3	0.7	3.1	5.3	0.5	8.1	9.5	12.8	6.8	12.7	1.7	14.7	33.1	22.8	14.7	12.3	0.1	0.1	0.1	14.6	0.4	8.1	0.0	2.0	3.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.5	0.0	1.4	0.0	0.0	1.2	15.2	13.4	10.5	19.8	12.9	8.1	11.3	10.2	9.5	8.8
GID8	"bA305P22.1, C20orf11, FLJ20602, TWA1"	ENSG00000101193	"GID complex subunit 8 homolog"	Q9NWU2	20	62938119-62948475	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049929, HPA055047"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA049929: , HPA055047: "	"unprognostic (1.35e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.90e-2)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (1.19e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.22e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.87e-2)"	14.0	14.1	23.0	15.4	18.7	35.5	21.5	20.7	23.5	20.8	18.6	14.3	21.0	15.1	18.2	19.5	55.9	23.0	19.0	15.9	17.4	10.9	15.6	29.6	15.2	24.2	15.5	22.9	30.6	30.0	22.2	15.7	15.1	14.7	17.8	16.1	17.7	21.2	17.7	19.7	34.0	17.1	19.8	14.1	19.6	20.1	22.4	17.2	23.6	20.6	26.0	24.6	22.8	28.7	9.3	9.8	16.0	10.4	12.9	15.0	8.3	15.6	10.0	15.0	13.5	12.4	9.8	14.7	8.8	7.3	25.2	11.4	48.2	15.3	19.7	15.1	11.3	18.2	13.7	18.2	15.3	5.2	6.7	18.3	13.0	23.0	9.8	21.2	15.5	10.7	20.3	10.8	12.6	12.2	14.0	8.5	8.6	22.0	25.2	19.0	15.1	15.0	20.0	28.2	11.7	9.2	22.1	15.6	12.8	20.7	20.4	12.7	28.3	20.5	12.2	15.1	18.9	11.8	11.8	9.0	10.3	20.5	10.2	10.4	9.5	5.8	10.4	16.0	11.7	8.7	13.7	8.4	12.3	13.0	9.8	9.3	13.6	15.0	15.2	12.9	8.1	7.4	10.6	8.3	23.0	18.7	20.7	23.5	17.4	10.9	15.5	22.9	14.7	17.2
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"		"HPA074472: "	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	3.5	0.0	30.0	0.0	25.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.1	0.0	10.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	6.7	0.0	0.0	0.0	12.5	9.9	0.0	0.0	3.9	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379569-6393981	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA022793: AB_1857946, HPA028707: , HPA070752: "	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favourable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favourable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	24.9	26.0	32.5	26.6	33.1	41.1	22.6	60.7	47.3	25.5	24.7	18.8	26.1	35.2	31.7	22.6	30.8	29.9	26.5	22.9	28.9	25.9	24.4	21.7	19.8	34.9	23.9	36.3	59.8	40.7	31.8	33.4	19.9	26.6	24.6	16.3	22.3	33.9	24.4	25.6	21.8	31.9	27.6	26.4	26.7	26.4	39.4	23.1	23.6	36.4	19.7	22.2	26.0	39.8	24.4	21.5	28.4	21.4	19.0	23.8	14.1	38.0	28.1	20.4	32.5	13.8	22.4	16.1	26.8	25.2	33.5	32.0	29.4	15.1	23.3	37.7	17.5	34.7	19.2	17.0	16.4	35.4	24.4	32.2	20.9	26.1	24.0	37.4	26.2	23.5	22.8	23.9	18.2	19.7	39.4	31.6	18.5	26.5	37.1	21.3	37.0	35.8	34.3	22.7	29.7	18.6	21.9	25.1	34.5	27.7	21.3	29.5	27.0	29.8	27.8	26.3	22.2	45.3	37.7	56.1	63.0	25.1	32.7	39.2	29.4	7.0	21.4	14.0	20.5	20.6	23.8	24.4	18.4	19.5	16.9	23.3	21.7	18.8	28.4	19.0	19.1	21.5	17.6	14.1	32.5	33.1	60.7	47.3	28.9	25.9	23.9	36.3	26.6	23.1
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075926-33087201	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.4"	"Group enriched"	"Detected in some"	6	"HDLM-2: 46.1;REH: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 90.1"	"Group enriched"	"Detected in all"	8	"B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6"									"HPA011078, HPA058509"	Approved		Approved	"Nucleoplasm,Cell Junctions"			730000	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: "	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favourable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	29.6	31.9	9.8	52.8	15.1	6.9	22.0	6.1	7.7	15.5	11.8	14.9	6.9	14.4	15.3	23.4	9.8	11.0	26.6	29.6	9.7	10.4	25.5	12.4	79.9	99.4	23.5	6.0	10.8	10.5	4.3	11.5	6.2	19.6	19.4	6.6	22.2	25.0	15.4	6.1	14.8	33.7	8.9	35.3	88.8	15.8	4.3	16.2	51.9	14.2	20.7	69.3	35.5	11.9	57.8	90.1	1.1	40.6	2.8	7.6	23.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.2	0.0	0.0	0.0	0.0	46.1	2.1	1.2	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	22.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	5.8	0.1	3.8	0.0	0.0	0.0	0.2	18.7	1.1	5.3	40.6	0.7	57.8	1.9	7.6	90.1	56.9	0.7	4.2	0.4	2.8	17.0	25.7	7.2	23.5	9.8	15.1	6.1	7.7	9.7	10.4	23.5	6.0	19.6	16.2
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54032853-54035358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.8;ovary: 13.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;ASC TERT1: 6.1;HSkMC: 5.7;SH-SY5Y: 9.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Region enriched"	"Detected in single"	14	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.9"	"Region enriched"	"Detected in single"	40	"pons and medulla: 4.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.8	1.6	0.2	1.0	0.2	0.0	1.8	0.2	0.6	0.2	1.6	0.2	0.2	0.3	0.5	5.3	1.7	8.0	1.5	0.2	0.2	0.0	1.5	0.2	0.2	0.3	0.4	0.2	13.4	0.2	0.0	0.2	1.4	8.8	0.2	0.0	0.8	0.2	0.2	4.2	2.1	4.6	2.5	2.6	0.2	3.9	2.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.9	2.1	0.0	8.3	5.0	6.1	0.0	0.5	0.4	0.9	0.7	3.5	0.4	0.0	0.6	2.5	1.3	0.1	0.0	0.3	2.6	2.9	0.0	1.0	0.1	0.2	0.0	0.1	5.7	0.6	4.1	0.4	0.0	0.0	0.0	1.8	1.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	9.1	0.6	0.2	4.3	1.7	0.1	0.0	1.4	0.9	3.1	0.3	0.0	0.0	0.0	0.2	0.1	3.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.4	0.2	8.8	0.2
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.1;HEK 293: 21.6;RPTEC TERT1: 16.0;SK-MEL-30: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	31	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA054383: , HPA070349: "	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.7	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.1	1.6	0.1	1.5	0.0	0.2	0.0	21.6	0.2	0.0	0.0	0.3	0.0	0.0	4.9	1.4	0.0	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	16.0	2.5	1.3	2.1	0.3	0.0	6.0	0.0	0.0	2.7	0.2	0.1	1.4	1.1	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613630-44636781	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 6.0;intestine: 19.9;liver: 20.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.7;Hep G2: 8.1;SiHa: 6.3"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"									"HPA051811, HPA054591"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA051811: , HPA054591: "	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.8	0.1	0.1	12.2	0.1	0.5	0.1	0.1	0.1	0.6	0.1	0.1	0.4	20.6	0.1	0.1	0.1	0.1	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.1	0.0	19.9	0.1	0.6	0.1	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	6.0	1.2	0.0	0.0	0.2	0.4	0.8	0.0	0.5	0.0	0.0	0.7	0.5	0.6	0.0	0.6	13.7	0.4	0.0	1.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.3	8.1	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	6.3	2.2	0.0	0.3	0.0	2.5	0.4	0.5	0.6	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388218-90502243	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			890000	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	46.2	23.2	9.9	27.8	17.1	23.7	31.7	5.9	11.2	41.8	26.7	18.1	19.7	12.3	50.8	28.8	41.3	27.4	22.0	17.6	12.0	9.1	25.9	9.8	38.3	45.3	17.5	6.6	31.3	16.4	27.6	19.1	53.7	15.5	28.9	27.1	12.0	37.8	22.0	23.1	32.7	25.8	37.6	17.4	48.0	20.3	11.4	15.4	39.5	32.7	29.6	34.9	43.0	40.8	5.9	9.9	39.3	12.4	11.5	9.9	6.3	31.6	17.5	8.8	10.3	22.8	29.7	51.4	30.3	28.2	27.9	30.1	20.1	33.1	17.7	14.8	50.6	57.2	17.6	33.9	33.9	22.5	12.5	11.8	33.9	7.4	27.6	21.6	25.4	17.5	31.4	32.9	47.0	38.3	10.2	25.0	42.6	16.4	11.7	6.5	11.5	10.0	14.3	23.7	15.5	28.8	50.4	11.1	8.4	42.2	21.6	22.5	18.9	18.7	48.5	31.9	16.6	26.7	31.2	9.7	13.8	17.9	29.0	21.3	17.1	10.5	11.6	8.1	9.9	10.9	8.9	5.6	6.2	8.5	9.9	5.9	3.8	6.6	39.3	11.5	12.4	6.0	6.7	6.3	9.9	17.1	5.9	11.2	12.0	9.1	17.5	6.6	15.5	15.4
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501456	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"				"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: , HPA068982: "	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	18.9	42.4	12.0	16.2	22.0	22.6	18.3	22.3	24.9	19.0	16.2	14.8	14.3	16.6	20.4	17.9	19.7	17.6	14.4	13.6	10.7	11.8	18.2	21.1	22.4	31.1	10.3	16.7	23.1	17.0	20.3	23.6	23.2	21.7	16.5	19.7	19.2	17.1	15.8	27.3	18.6	25.3	15.5	13.7	25.5	15.7	18.0	12.3	39.6	27.8	14.0	20.3	17.8	18.4	7.1	9.5	7.1	7.8	7.2	8.8	3.4	7.4	13.2	20.6	12.9	18.2	12.0	13.9	12.7	9.9	11.6	10.6	13.0	13.0	27.6	8.7	10.6	14.5	47.9	12.9	10.3	8.7	16.6	23.9	13.9	9.1	9.5	25.7	25.8	12.6	8.8	8.9	10.9	13.6	25.0	9.9	9.9	11.2	15.7	13.1	26.9	4.8	18.5	20.6	7.8	12.7	20.6	12.4	18.6	17.3	12.2	13.3	11.4	22.6	11.0	12.0	8.2	6.5	11.0	12.3	27.0	15.8	8.6	23.9	8.5	7.1	5.8	4.4	6.0	7.8	7.7	6.5	6.6	5.9	8.0	7.1	6.5	8.8	6.8	7.2	6.0	9.5	5.3	3.4	12.0	22.0	22.3	24.9	10.7	11.8	10.3	16.7	21.7	12.3
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 117.5;HaCaT: 45.0;HBEC3-KT: 100.3;hTCEpi: 34.3;RT4: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			79000	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	6.3	3.4	9.7	10.9	9.7	1.4	13.7	4.7	7.7	14.3	32.1	15.6	10.0	35.3	9.7	8.8	24.0	13.7	47.8	4.3	9.4	7.9	4.8	1.5	7.4	3.7	10.1	9.1	4.7	6.7	3.1	5.7	50.0	17.2	19.7	10.4	9.8	52.3	13.2	2.4	47.0	58.5	7.4	10.7	17.0	41.0	3.9	9.8	1.8	3.2	22.1	15.9	17.2	20.5	2.4	8.2	1.3	0.7	0.0	2.2	0.8	21.8	19.3	0.0	0.2	0.0	0.1	26.6	0.1	0.0	0.0	0.1	2.0	117.5	0.0	4.2	0.0	45.0	0.1	100.3	0.0	0.1	0.0	0.1	4.9	2.1	0.1	0.0	0.2	0.1	34.3	0.0	21.4	0.7	0.0	2.0	0.0	12.2	0.2	0.2	0.1	16.8	0.3	0.5	0.2	26.8	33.0	0.0	0.2	0.6	2.0	0.3	8.4	0.2	2.2	0.6	1.0	0.0	0.2	0.7	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.0	0.7	0.7	2.2	1.4	0.3	1.0	0.1	2.4	0.9	0.6	1.3	0.0	0.0	8.2	1.4	0.8	9.7	9.7	4.7	7.7	9.4	7.9	10.1	9.1	17.2	9.8
JCAD	KIAA1462	ENSG00000165757	"Junctional cadherin 5 associated"	Q9P266	10	30012800-30115494	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 14.8;HUVEC TERT2: 15.3;LHCN-M2: 12.8;TIME: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017956	Enhanced		Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"		"HPA017956: AB_1852408"	"unprognostic (1.78e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.37e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.09e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (2.54e-4)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.34e-2)"	27.0	7.5	6.2	9.1	12.4	0.5	18.0	2.2	8.8	10.1	29.4	3.2	5.4	1.7	16.5	8.1	5.9	10.8	9.9	16.3	6.2	4.7	6.0	2.0	22.3	3.2	6.7	8.9	11.3	15.7	4.7	4.8	30.5	8.9	14.1	4.1	24.4	2.5	9.7	9.2	3.7	3.7	27.8	6.8	1.2	5.0	13.0	4.4	1.4	13.0	3.9	2.0	18.3	22.8	0.2	0.1	0.8	0.0	0.3	0.2	0.0	7.5	3.4	3.1	0.0	1.9	0.4	4.5	4.1	4.3	0.6	1.0	1.3	0.0	0.0	0.3	14.8	0.1	0.8	0.2	1.7	0.8	1.8	0.0	0.0	0.0	8.5	0.0	0.5	4.8	0.1	10.3	0.7	15.3	0.0	0.0	12.8	0.2	0.0	0.3	0.6	5.2	0.0	1.7	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.7	34.4	7.8	1.9	2.4	0.3	3.2	0.4	0.0	1.8	5.2	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.0	6.2	12.4	2.2	8.7	6.2	4.7	6.7	8.9	8.9	4.4
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061765-90185857	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;parathyroid gland: 14.3;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.3;RT4: 5.1;SCLC-21H: 2.2;SK-BR-3: 2.2;U-2 OS: 2.5;U-266/84: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;monocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"				"Nuclear speckles, Cell Junctions"		"HPA003514: "	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.8	1.1	2.9	2.2	3.5	0.1	0.4	0.2	4.2	0.4	0.6	4.0	0.0	0.6	0.3	1.5	0.3	0.4	0.5	2.7	2.9	2.4	4.8	0.7	0.7	1.6	6.3	1.4	0.4	2.7	14.3	0.6	1.2	3.6	0.4	0.7	0.1	1.1	0.7	0.1	0.1	0.7	0.4	8.3	1.1	0.5	13.2	5.4	0.7	2.7	0.0	0.6	0.8	0.1	0.0	3.8	0.0	1.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.9	1.2	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.5	5.1	2.2	0.7	0.0	2.2	1.4	0.0	1.9	0.0	0.0	2.5	0.0	0.8	0.7	2.2	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	2.9	3.5	0.2	4.2	2.9	2.4	6.3	1.4	3.6	5.4
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513189	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: "	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	1.3	4.4	19.8	2.3	28.6	2.0	2.0	20.0	38.1	2.0	1.5	6.0	0.2	6.2	1.4	1.5	2.3	1.6	1.9	1.7	17.2	11.1	2.5	1.3	3.2	2.2	6.5	23.8	1.3	2.1	8.5	6.1	2.1	12.5	3.5	1.2	1.6	5.2	3.1	1.2	2.4	4.0	1.2	6.6	1.8	2.9	1.5	10.3	0.0	2.3	0.0	2.2	1.6	1.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	4.5	3.0	0.3	0.0	0.0	0.0	4.4	0.0	0.2	0.0	0.1	2.2	3.6	1.6	1.2	0.0	2.1	0.3	1.6	0.0	0.0	1.2	0.2	0.3	0.7	0.0	0.0	8.4	0.2	0.9	0.0	0.0	0.1	1.4	2.8	0.0	3.0	0.6	0.8	1.1	0.9	3.8	0.0	1.3	1.1	0.7	0.7	2.8	0.1	10.0	0.0	3.8	0.2	0.1	0.0	0.8	0.1	0.0	9.3	7.5	0.4	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	19.8	28.6	20.0	38.1	17.2	11.1	6.5	23.8	12.5	10.3
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"			"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: "	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	16.9	2.5	11.8	1.7	24.6	0.8	13.2	4.4	33.3	5.9	7.2	1.5	11.2	8.3	4.5	3.2	21.7	5.6	4.8	6.9	6.1	5.5	10.0	3.7	2.5	1.8	3.8	11.6	2.1	12.9	10.8	5.0	21.6	4.8	5.1	5.6	2.0	22.1	10.0	5.1	10.0	8.2	2.8	1.3	0.9	8.0	4.1	2.0	0.7	15.0	5.7	7.8	5.8	7.7	1.4	1.1	1.5	1.9	3.8	1.6	0.6	1.6	0.6	1.9	1.0	3.5	7.3	9.2	1.5	0.7	0.0	0.0	2.7	8.4	2.1	1.2	4.2	1.6	0.0	0.3	0.0	0.5	4.6	2.9	1.7	1.6	1.4	2.7	0.8	5.4	0.3	0.5	0.0	2.8	1.7	1.0	6.6	4.7	2.4	1.8	4.8	1.0	1.5	0.7	0.9	6.3	8.8	2.3	2.6	0.7	9.7	1.0	5.2	1.4	8.0	10.5	3.1	3.4	1.8	3.9	0.6	1.4	9.6	2.4	1.9	1.5	0.5	0.3	1.0	0.5	1.5	1.4	1.5	1.5	0.8	0.9	1.6	1.2	0.4	3.8	1.9	1.1	1.3	0.6	11.8	24.6	4.4	33.3	6.1	5.5	3.8	11.6	4.8	2.0
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793428-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 13.7;testis: 23.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.5;HEL: 9.4;HL-60: 9.9;NTERA-2: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	7	"B-cells: 2.2;dendritic cells: 4.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules"				"Cell Junctions, Microtubules"		"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	2.8	1.1	4.8	1.2	9.6	2.7	2.3	1.1	4.0	2.3	0.9	4.2	1.4	1.0	1.9	3.9	1.0	13.7	1.1	2.0	4.1	3.8	2.1	0.9	3.4	1.9	3.5	5.6	2.2	0.5	1.0	7.9	0.9	11.8	2.0	0.7	2.6	1.3	2.4	0.9	1.0	1.1	2.0	3.6	1.8	1.1	23.8	4.8	1.7	2.7	0.5	1.2	1.0	0.9	2.2	4.6	0.1	0.3	0.0	0.5	0.4	2.7	0.4	0.8	0.0	1.1	4.1	0.0	1.2	2.4	2.8	2.7	0.1	0.0	1.6	0.0	0.7	0.0	2.5	0.0	1.0	0.4	7.5	9.4	0.1	0.0	0.7	9.9	2.5	1.4	0.5	1.1	0.0	1.8	0.2	0.0	1.1	0.0	0.9	2.0	10.0	3.1	4.9	0.0	0.5	2.3	0.2	4.9	3.8	0.8	0.1	0.0	0.0	4.8	0.4	0.6	0.0	0.3	0.0	0.0	0.0	2.3	4.5	0.1	2.7	0.0	0.2	0.0	0.0	0.3	0.2	2.2	0.0	0.0	1.4	1.5	0.0	0.0	0.1	0.0	0.0	4.6	0.5	0.4	4.8	9.6	1.1	4.0	4.1	3.8	3.5	5.6	11.8	4.8
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031852, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031852: , HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favourable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	18.0	6.0	10.1	6.4	9.8	1.0	16.5	38.6	16.8	6.9	11.2	10.1	25.7	10.7	11.6	7.6	9.4	12.6	19.7	11.1	9.4	11.8	14.3	17.6	13.3	2.9	8.8	10.4	4.3	16.7	18.7	13.1	11.1	9.6	9.2	9.5	7.7	17.4	37.9	7.7	13.0	11.6	7.9	8.3	13.9	19.8	10.7	7.7	0.6	23.2	5.8	4.4	6.9	13.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.8	1.5	8.7	0.9	1.7	1.3	3.9	4.8	4.1	1.8	2.8	10.3	2.4	0.0	0.7	5.7	0.8	2.4	1.6	2.9	0.0	1.3	24.5	3.0	6.9	1.1	0.0	0.8	1.9	1.4	6.3	1.3	4.2	10.3	0.0	1.9	2.1	0.0	0.0	11.6	1.5	0.0	2.4	0.6	2.2	9.3	2.8	7.6	1.9	2.3	0.0	4.5	0.0	1.1	5.9	4.3	1.5	1.9	0.0	0.0	0.0	3.4	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	9.8	38.6	15.5	9.4	11.8	8.8	10.4	9.6	7.7
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: "	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	10.7	13.2	23.7	9.4	21.0	3.1	14.4	25.0	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13.0	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	17.9	15.5	20.4	10.5	11.3	14.7	13.0	12.3	16.2	14.0	13.4	9.2	6.2	7.5	10.0	19.1	12.1	17.7	17.1	21.1	13.2	20.8	8.3	9.1	17.3	13.3	7.9	12.6	12.1	17.0	16.4	17.2	12.7	8.8	4.4	17.6	6.7	9.6	7.4	11.9	7.6	11.8	22.9	5.1	19.2	11.6	4.1	12.1	14.2	7.6	11.8	9.6	5.8	11.6	6.9	10.7	9.5	14.5	8.7	9.7	5.9	13.0	6.3	10.0	0.6	2.7	2.0	3.0	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2.0	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21.0	25.0	42.7	31.7	29.3	24.5	27.1	23.4	9.8
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.4;HHSteC: 27.1;HSkMC: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"HPA039936: AB_10795239, HPA071996: "	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favourable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavourable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	8.0	8.7	12.3	5.8	16.0	3.0	5.1	40.3	20.6	14.1	6.1	7.0	7.8	3.6	15.1	5.8	4.6	11.5	16.1	4.2	9.4	7.7	4.5	1.4	8.8	4.5	6.4	14.7	13.7	1.8	3.0	12.7	7.3	10.8	5.9	4.6	9.5	2.4	13.5	1.2	4.5	4.1	16.9	5.3	5.3	3.9	6.5	7.4	2.7	4.3	1.4	3.2	11.3	6.4	0.3	0.6	3.4	1.7	0.6	2.8	0.5	0.2	7.5	4.7	7.3	28.4	15.2	0.6	5.1	9.6	5.6	5.6	0.1	0.9	1.7	2.9	5.4	0.0	2.1	3.4	2.2	2.5	2.6	1.8	3.8	0.0	27.1	0.0	1.9	27.0	2.4	7.6	4.0	8.7	0.0	8.1	5.3	3.3	1.8	0.4	1.6	2.8	2.6	3.2	0.4	2.8	0.0	4.7	6.4	2.7	3.5	7.2	2.4	4.7	6.4	5.4	5.8	2.4	1.3	3.3	3.7	0.0	8.7	3.3	5.2	0.0	1.7	0.0	1.5	1.3	2.8	0.3	2.1	2.3	0.6	0.0	0.9	1.2	3.4	0.6	0.4	0.3	0.4	0.5	12.3	16.0	40.3	20.6	9.4	7.7	6.4	14.7	10.8	7.4
MEPCE	"BCDIN3, FLJ20257, MePCE"	ENSG00000146834	"Methylphosphate capping enzyme"	Q7L2J0	7	100428790-100434126	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026384, HPA051587"	Supported		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"CAB026384: , HPA051587: "	"unprognostic (8.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (6.01e-6)"	"unprognostic (1.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.09e-1)"	"prognostic favourable (1.01e-10)"	"unprognostic (9.66e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.57e-1)"	"unprognostic (9.50e-3)"	17.5	24.1	17.7	13.9	22.8	18.5	15.0	24.1	24.1	15.7	14.0	16.7	26.9	14.1	18.8	22.5	16.1	18.6	22.9	12.4	20.1	13.7	18.7	20.8	13.5	19.7	19.7	16.4	29.2	18.3	32.5	15.0	19.0	19.3	15.8	10.2	17.2	18.5	24.2	21.4	26.1	15.8	15.7	17.7	34.9	14.4	63.1	20.4	21.7	25.7	17.1	17.9	16.3	20.4	8.4	8.7	9.3	3.6	7.3	9.1	10.6	13.5	17.5	13.0	13.9	12.6	12.7	9.6	15.1	22.2	16.4	12.7	14.3	19.9	27.9	25.3	9.5	12.5	14.2	11.5	10.9	12.5	16.1	14.4	13.5	10.7	10.7	18.3	17.8	13.1	13.8	18.7	23.8	13.6	28.3	20.7	15.7	50.3	20.9	41.8	24.0	19.6	16.9	10.5	25.3	11.0	8.4	19.6	16.9	23.7	46.5	15.8	11.8	16.8	11.7	27.7	21.5	18.6	19.9	13.8	13.0	31.1	15.5	23.0	24.2	2.5	3.6	4.8	5.6	3.2	6.5	8.0	6.4	6.0	4.4	8.4	9.1	8.0	9.3	7.3	2.6	8.7	5.7	10.6	17.7	22.8	24.1	24.1	20.1	13.7	19.7	16.4	19.3	20.4
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 14.3;RT4: 23.4;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306"	Approved		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"			Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: "	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favourable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.1	3.4	15.0	1.3	19.6	2.7	10.2	4.9	19.4	11.4	2.1	21.1	4.2	1.0	4.9	32.9	1.2	4.0	2.6	1.9	15.4	11.1	25.6	29.5	2.7	1.2	21.8	10.0	1.1	1.6	5.7	3.3	5.5	21.1	2.9	2.2	17.5	2.0	11.7	4.2	19.7	1.1	3.9	16.4	1.7	1.3	30.6	20.8	0.0	2.8	0.2	1.0	11.9	1.5	0.0	0.7	7.9	0.8	0.0	0.8	6.9	0.2	3.5	1.9	1.9	1.6	0.8	0.7	3.8	0.5	1.8	1.6	1.2	0.2	0.0	0.1	5.9	1.8	6.8	0.8	0.8	0.0	2.6	0.0	3.7	1.4	0.9	0.0	14.3	1.1	2.1	0.2	0.6	0.2	0.5	0.7	3.6	2.0	0.6	0.5	2.0	3.0	0.0	1.1	0.0	5.1	23.4	1.6	3.5	3.2	21.6	6.9	1.2	0.0	0.1	1.8	7.1	3.5	7.3	0.3	0.0	0.0	4.8	0.7	7.1	7.9	0.2	2.1	0.8	0.8	0.4	0.0	0.7	0.2	0.3	0.0	0.3	0.1	4.9	0.0	0.0	0.7	0.1	6.9	15.0	19.6	4.9	15.4	15.4	11.1	21.8	10.0	21.1	20.8
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"				Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favourable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	10.1	14.3	7.7	11.5	10.2	17.3	6.8	17.6	16.0	5.6	17.2	8.9	14.6	23.7	7.6	8.7	11.5	7.1	13.3	24.4	7.9	11.6	7.6	7.4	5.2	7.5	9.0	10.9	8.4	6.8	7.5	8.5	3.1	9.4	9.3	5.5	8.7	11.1	12.3	13.0	9.8	21.6	9.0	7.6	7.1	9.9	7.0	7.2	8.0	9.6	5.3	10.8	10.0	9.8	2.8	3.9	8.5	3.1	1.2	6.5	2.2	4.0	8.3	2.6	13.0	7.1	3.7	5.7	7.2	5.5	8.4	5.3	7.1	8.4	6.1	3.3	5.6	19.2	3.5	5.4	1.3	5.6	5.1	4.4	16.1	5.2	7.9	4.9	10.1	5.2	4.3	7.5	3.9	5.7	6.4	2.6	4.5	10.6	4.9	10.3	5.9	12.0	10.2	7.6	10.0	4.4	7.8	8.2	5.8	8.0	12.9	4.5	9.2	5.4	5.7	5.4	6.2	9.1	5.5	3.5	5.0	5.6	7.7	4.0	6.4	8.5	2.6	2.4	3.0	3.1	6.5	2.3	2.2	3.9	2.9	2.8	2.2	1.3	4.8	1.2	1.7	3.9	1.9	2.2	7.7	10.2	17.6	16.0	7.9	11.6	9.0	10.9	9.4	7.2
MOAP1	"MAP-1, PNMA4"	ENSG00000165943	"Modulator of apoptosis 1"	Q96BY2	14	93182196-93184928	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000939	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"HPA000939: AB_1079402"	"unprognostic (9.40e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (7.37e-9)"	"unprognostic (1.98e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.58e-2)"	"prognostic favourable (3.15e-6)"	"unprognostic (6.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	6.9	14.5	21.9	5.7	30.0	15.9	8.6	30.5	69.5	12.8	10.1	7.1	7.7	7.1	9.3	12.0	8.0	11.1	8.2	23.9	24.2	35.9	14.2	9.0	9.7	7.9	22.9	27.8	8.6	9.0	25.0	12.0	7.1	27.8	15.0	7.4	10.1	8.2	14.9	13.9	5.2	7.0	10.1	11.2	7.8	8.3	4.4	7.8	5.9	10.6	3.6	7.5	8.4	3.8	6.3	4.2	16.4	4.4	8.8	14.3	7.5	3.8	3.0	7.3	9.8	6.3	2.4	4.9	4.5	5.2	4.7	5.3	3.2	3.8	11.6	8.3	5.2	6.0	5.2	4.5	5.2	5.3	6.6	6.5	6.1	4.3	8.2	5.8	11.8	4.3	6.8	2.8	5.7	5.7	2.3	7.1	5.3	15.9	9.1	5.5	3.3	3.9	5.6	9.9	7.0	11.9	10.9	16.8	14.6	4.6	6.5	18.4	10.0	4.3	6.2	1.8	2.9	4.2	2.2	13.4	13.7	7.0	4.8	3.7	3.2	16.4	4.0	10.3	11.3	4.4	12.6	6.0	10.5	11.5	4.2	6.3	14.3	12.2	3.7	8.8	4.4	4.0	9.8	7.5	21.9	30.0	30.5	69.5	24.2	35.9	22.9	27.8	27.8	7.8
MPP7	FLJ32798	ENSG00000150054	"Membrane palmitoylated protein 7"	Q5T2T1	10	28050993-28334486	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 10.7;CACO-2: 20.2;CAPAN-2: 12.6;T-47d: 40.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037597, HPA037598"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA037597: , HPA037598: AB_10696941"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.64e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.31e-3)"	"prognostic favourable (5.88e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (2.79e-14)"	"unprognostic (2.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	1.9	1.2	1.9	3.2	1.9	2.6	3.7	3.2	3.0	2.3	6.3	1.9	1.9	1.8	1.9	3.7	16.3	4.6	2.0	2.0	1.9	0.6	4.9	1.9	3.7	4.6	1.9	1.9	1.9	11.3	1.8	7.8	4.2	2.2	2.8	3.5	2.6	5.0	1.9	4.7	11.2	3.3	3.0	1.9	2.4	5.9	33.2	1.9	1.9	5.7	1.9	3.0	3.4	5.4	0.7	8.1	9.0	8.2	4.9	9.2	5.3	2.6	0.0	0.2	0.0	0.0	0.0	10.7	0.5	0.4	2.2	3.5	20.2	12.6	0.0	0.1	1.5	4.7	1.8	3.4	5.1	0.0	3.4	0.0	0.6	1.2	0.0	0.0	0.0	0.1	5.3	0.3	0.2	0.0	0.4	0.0	2.8	4.8	1.0	0.0	0.6	0.9	0.5	6.1	0.0	0.2	8.5	0.5	0.0	1.0	5.2	0.0	40.8	0.5	0.0	0.8	5.9	0.0	0.4	0.1	0.0	0.0	0.0	4.8	0.0	0.0	8.2	9.0	4.3	2.7	6.3	0.7	4.7	2.9	8.1	0.6	9.2	6.4	3.3	4.9	1.4	0.1	1.1	5.3	1.9	1.9	3.2	3.0	1.9	0.6	1.9	1.9	2.2	1.9
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617709-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"				Mitochondria	"Cell Junctions"	"HPA043485: , HPA050334: "	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	17.1	18.9	9.9	10.3	10.7	5.4	16.0	8.5	13.1	11.6	13.4	12.8	11.9	12.8	9.3	15.5	15.5	16.5	12.3	26.6	9.0	8.0	22.4	49.1	10.5	17.3	13.1	9.3	16.4	21.8	17.4	10.2	11.8	9.1	10.9	16.4	10.1	17.1	18.0	55.4	13.7	14.0	10.4	12.4	14.4	13.5	10.2	11.2	13.5	21.5	31.1	15.6	11.2	9.3	15.7	8.9	6.3	10.2	12.4	15.2	11.2	9.5	5.8	4.6	6.6	7.0	9.5	8.5	3.6	8.2	11.2	7.0	9.0	4.6	9.8	8.3	5.5	7.7	10.7	10.0	11.0	5.9	11.4	9.5	4.5	10.5	6.2	8.9	4.2	8.2	12.6	9.3	25.5	6.3	14.4	9.5	10.2	7.3	5.9	5.5	3.3	7.4	7.8	6.3	18.8	10.4	4.0	10.1	3.3	3.2	13.4	13.5	17.2	4.7	3.6	7.4	7.1	4.2	6.1	8.0	9.6	8.3	3.5	13.6	10.8	6.3	8.0	4.0	9.1	10.1	12.3	15.7	12.1	9.8	8.9	14.7	15.2	12.2	0.6	12.4	10.2	8.1	11.4	11.2	9.9	10.7	8.5	13.1	9.0	8.0	13.1	9.3	9.1	11.2
MTFR1L	FAM54B	ENSG00000117640	"Mitochondrial fission regulator 1 like"	Q9H019	1	25818640-25832942	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027124, HPA027130"	Approved		Approved	"Cell Junctions,Mitochondria"				Mitochondria	"Cell Junctions"	"HPA027124: AB_10600211, HPA027130: AB_10611251"	"unprognostic (9.90e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.29e-2)"	"prognostic favourable (6.81e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-3)"	"unprognostic (5.33e-2)"	"prognostic favourable (5.89e-12)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.33e-1)"	13.2	43.5	17.8	8.1	23.9	6.2	14.0	19.4	26.5	13.8	20.2	17.1	21.6	18.2	16.7	23.3	19.2	17.1	13.4	58.7	16.8	17.6	27.7	25.1	10.7	9.0	17.7	20.7	26.8	14.5	38.7	16.4	15.6	19.2	19.9	14.8	24.2	16.3	28.8	76.9	11.4	15.3	28.0	13.0	13.4	16.4	46.4	15.0	5.8	16.5	23.1	9.9	21.1	16.6	10.1	21.1	41.1	20.3	10.3	10.6	18.1	7.6	10.5	21.3	21.6	27.7	26.2	9.0	17.8	25.3	18.2	20.1	3.4	15.9	2.6	15.8	31.4	7.0	17.4	15.2	18.0	17.2	15.7	21.8	17.6	13.8	26.6	17.8	21.9	26.9	14.4	19.4	14.6	14.9	13.2	11.7	26.0	8.0	10.1	12.7	11.7	15.5	10.2	19.2	7.6	18.8	7.0	21.8	19.9	13.3	12.9	26.5	10.8	16.6	15.4	15.1	12.0	35.2	11.1	12.3	7.4	9.2	26.4	24.3	16.7	20.4	19.4	41.1	10.4	18.8	6.2	10.1	9.9	9.3	21.1	10.0	10.6	9.7	5.2	10.3	20.3	8.5	10.3	18.1	17.8	23.9	19.4	26.5	16.8	17.6	17.7	20.7	19.2	15.0
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"			30000	Cytosol	"Cell Junctions"	"HPA041404: , HPA048250: "	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	11.9	18.5	15.8	16.9	19.7	7.6	12.5	21.7	27.9	10.8	19.4	17.1	10.8	39.6	8.4	7.3	30.0	7.4	8.7	11.9	17.2	18.2	9.2	25.9	14.6	12.6	14.6	17.3	11.1	19.0	11.0	7.8	7.6	24.5	13.7	5.1	10.8	16.1	8.7	27.8	18.3	20.7	6.6	23.8	11.1	21.2	23.0	14.6	4.3	9.2	18.6	12.2	7.3	13.8	15.0	17.6	2.5	8.9	18.1	18.1	9.4	14.6	9.4	15.7	10.2	5.3	11.8	8.9	7.3	7.6	5.0	4.2	24.8	37.1	7.1	11.7	4.3	21.8	7.0	38.6	1.4	4.4	11.9	5.2	5.2	37.7	10.8	3.3	3.7	9.3	7.4	13.2	4.2	5.3	14.4	3.9	2.7	34.2	11.1	16.8	18.9	9.2	11.7	4.5	18.3	14.6	9.2	15.9	5.3	18.1	4.1	5.3	20.6	14.8	11.3	4.6	9.4	8.2	4.1	10.8	4.8	24.2	5.6	16.2	7.6	2.5	8.2	1.5	18.1	8.6	13.5	10.3	12.1	11.9	9.5	15.0	9.4	11.5	1.1	18.1	8.9	17.6	12.6	9.4	15.8	19.7	21.7	27.9	17.2	18.2	14.6	17.3	24.5	14.6
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: , HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	18.9	12.6	4.6	7.6	19.4	22.6	7.5	6.0	34.0	12.2	21.6	7.4	11.5	15.9	14.4	6.7	15.0	8.4	18.1	26.8	9.4	9.1	6.4	5.4	5.8	72.5	12.4	11.9	21.6	20.7	21.8	25.5	38.8	13.4	60.9	14.5	9.9	12.3	5.2	8.8	10.2	5.9	6.5	34.9	11.6	17.8	9.3	5.1	8.4	18.5	21.4	5.9	3.6	33.0	18.2	14.1	26.1	11.0	42.0	23.8	22.8	108.1	14.1	26.9	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1
NECTIN2	"CD112, HVEB, PRR2, PVRL2, PVRR2"	ENSG00000130202	"Nectin cell adhesion molecule 2"	Q92692	19	44846175-44889228	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 11.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012759, CAB026138, HPA073459"	Enhanced		Approved	"Nucleoli fibrillar center,Cell Junctions"			3400000	"Nucleoli fibrillar center, Cell Junctions"		"CAB026138: , HPA012759: AB_1846227, HPA073459: "	"unprognostic (3.30e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.05e-1)"	29.5	28.2	7.9	15.6	7.7	5.6	38.0	4.5	9.0	24.2	34.0	9.3	22.3	24.2	23.2	27.4	33.6	16.7	54.1	21.9	10.5	8.1	29.0	53.7	39.6	23.0	8.2	6.8	25.5	20.6	22.5	15.9	45.8	11.2	25.8	14.8	22.9	24.4	28.9	14.6	18.3	42.9	13.8	8.4	31.4	26.2	38.7	5.8	3.8	32.2	19.2	24.1	21.6	31.4	0.0	3.3	11.5	2.6	0.0	0.3	0.7	17.8	21.4	27.7	32.7	14.0	8.5	32.2	15.3	18.9	27.1	31.3	44.1	39.3	0.1	20.7	17.7	24.5	24.5	12.6	21.6	0.7	12.8	10.8	7.4	28.5	33.7	0.1	29.0	14.9	5.1	12.9	10.5	35.0	17.6	0.1	13.5	32.5	0.1	1.2	23.0	6.4	1.0	9.4	0.7	32.1	22.1	1.3	3.7	19.0	28.9	6.5	22.5	10.6	34.9	7.4	26.3	5.5	11.2	2.2	6.4	0.1	13.6	2.3	19.3	1.5	2.6	11.5	0.0	0.9	0.3	0.0	0.1	0.0	3.3	0.0	0.0	0.0	2.4	0.0	0.5	0.3	0.0	0.7	7.9	7.7	4.5	9.0	10.5	8.1	8.2	6.8	11.2	5.8
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"			86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.9	3.0	3.0	6.9	10.1	3.8	5.9	2.7	9.3	8.1	11.8	17.4	3.3	1.0	7.0	3.6	1.7	6.3	2.5	3.1	2.5	4.2	1.5	1.8	20.3	18.1	1.9	8.5	6.3	4.7	9.7	5.0	7.2	3.2	7.2	4.1	5.3	1.6	2.9	2.3	2.4	2.1	1.6	10.4	13.3	6.5	2.3	1.3	3.0	4.0	7.1	7.7	8.7	3.0	5.3	3.1	7.4	4.8	8.9	14.2	2.1	3.9	4.8	3.7	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Group enriched"	"Detected in some"	4	"AF22: 16.5;EFO-21: 19.5;HUVEC TERT2: 18.0;TIME: 10.4;U-937: 13.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049771	Uncertain		Approved	"Plasma membrane,Cell Junctions"				"Cell Junctions"	"Plasma membrane"	"HPA049771: "	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	7.8	2.3	11.0	4.8	22.5	3.4	5.2	27.1	9.4	6.6	5.5	1.5	0.9	1.3	8.7	2.7	5.5	3.8	7.4	3.6	4.9	3.2	2.0	1.6	5.5	1.3	2.2	4.9	3.1	1.6	3.1	6.1	3.7	4.3	6.4	3.3	6.2	2.6	8.7	2.8	2.3	2.6	11.7	2.4	4.5	3.4	9.6	2.7	0.3	5.3	4.6	1.6	6.3	4.4	0.0	3.5	13.5	5.7	0.9	1.8	1.7	0.2	0.4	16.5	0.0	0.2	0.7	0.1	0.5	3.0	0.1	0.2	0.1	0.0	0.1	19.5	1.6	0.0	1.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.6	0.0	18.0	0.0	2.7	0.1	0.1	0.1	1.3	3.1	0.0	0.0	0.9	0.0	0.1	1.8	0.4	3.8	0.0	0.0	0.0	0.0	1.1	10.4	0.0	1.0	1.3	0.0	0.0	0.0	0.1	0.7	13.1	0.0	4.1	5.7	11.8	1.8	3.9	1.7	0.0	1.0	1.6	3.5	0.0	0.1	0.2	13.5	0.9	3.0	0.0	0.1	1.7	11.0	22.5	27.1	9.4	4.9	3.2	2.2	4.9	4.3	2.7
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.9"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;NTERA-2: 7.9;SH-SY5Y: 4.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"			"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: "	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	1.4	8.9	16.3	1.6	19.4	2.2	1.3	11.5	45.9	3.2	1.6	30.0	0.1	1.1	4.2	8.1	1.5	6.0	2.4	2.1	15.7	9.7	1.2	0.9	1.3	1.2	12.7	13.1	6.1	1.2	1.4	1.1	1.5	15.2	7.9	1.4	1.6	1.6	16.0	0.8	1.6	1.6	2.9	12.9	1.4	1.5	3.8	12.3	0.0	1.0	0.0	1.1	1.5	1.3	0.2	0.1	3.3	0.3	0.3	0.5	0.0	0.1	0.8	10.9	0.3	2.6	1.1	1.9	0.3	0.1	0.0	0.2	0.1	0.5	0.8	0.8	0.1	0.2	0.4	0.0	0.2	0.7	1.3	0.5	0.5	0.1	0.0	0.2	0.9	0.6	0.1	0.3	0.0	0.1	0.7	2.1	0.1	0.6	0.7	1.7	7.9	0.0	0.9	0.4	0.5	0.0	1.2	2.7	4.3	0.3	0.0	0.9	0.0	0.5	0.3	0.2	1.3	0.4	0.0	1.7	1.5	0.6	0.3	0.4	0.6	0.3	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	3.3	0.3	0.0	0.1	0.1	0.0	16.3	19.4	11.5	23.1	15.7	9.7	12.7	13.1	15.2	12.3
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 20.9;CAPAN-2: 27.8;HaCaT: 22.4;MCF7: 22.1;RPTEC TERT1: 17.3;RT4: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"			"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: , CAB068213: , CAB068214: , HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favourable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.8	3.4	3.8	3.7	0.5	7.6	3.9	2.9	4.3	15.5	3.2	21.9	10.2	1.7	7.4	10.6	7.9	17.1	1.1	4.0	2.9	15.3	31.7	29.2	0.4	4.0	1.7	2.3	33.2	12.0	3.2	9.0	6.7	5.7	10.9	7.7	7.1	25.0	0.5	8.7	24.5	1.2	3.8	2.1	15.1	2.0	1.5	0.4	58.1	9.8	8.6	5.0	6.5	1.2	1.2	1.8	0.3	2.0	0.9	0.1	15.0	6.1	0.1	0.5	0.2	0.3	12.2	0.0	1.5	2.0	3.0	20.9	27.8	0.1	5.3	0.3	22.4	6.2	3.0	5.6	0.1	10.8	1.1	0.2	6.3	0.1	0.5	1.5	0.0	3.1	4.7	0.2	1.2	0.0	0.1	0.0	22.1	0.6	0.4	2.4	2.5	0.0	4.6	0.5	17.3	18.9	2.0	0.9	0.1	16.5	0.2	9.3	1.9	0.2	0.1	6.2	1.2	1.5	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.7	0.8	0.2	0.2	0.8	0.9	0.3	0.1	1.2	0.7	0.9	1.8	2.0	0.2	1.2	0.4	0.1	3.4	3.7	3.9	2.9	4.0	2.9	4.0	1.7	6.7	1.5
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 44.6;MCF7: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (9.85e-4)"	"prognostic favourable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	6.8	11.1	11.0	12.7	12.3	4.8	11.9	13.7	12.4	17.3	19.6	13.7	19.9	26.0	12.2	17.3	20.1	15.3	16.5	8.1	10.9	8.1	19.4	17.0	18.7	5.4	13.7	7.7	13.8	29.6	11.2	17.0	23.0	10.3	29.6	8.1	19.7	40.9	18.5	10.3	18.6	25.1	9.0	8.3	7.9	18.6	22.3	12.5	8.8	15.2	10.1	14.7	11.5	15.0	2.8	3.4	4.2	2.5	3.6	4.5	1.9	17.6	44.6	6.6	10.1	2.1	2.2	20.1	8.4	3.4	5.7	5.7	29.2	15.0	4.0	12.8	5.3	6.5	3.6	6.7	2.1	10.7	10.2	4.8	8.1	14.2	3.4	4.8	7.0	2.7	3.0	5.3	3.8	7.4	9.5	3.2	3.4	49.1	5.1	5.3	12.1	10.7	5.2	5.2	3.0	5.5	19.4	21.3	14.7	8.6	38.3	9.5	17.0	8.0	12.3	9.7	16.7	11.1	15.0	3.6	3.4	3.3	11.9	2.9	11.6	1.0	2.5	4.2	2.6	1.4	3.6	2.2	2.9	4.5	3.4	2.8	2.2	2.2	2.1	3.6	2.1	2.9	3.0	1.9	11.0	12.3	13.7	12.4	10.9	8.1	13.7	7.7	10.3	12.5
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Cell Junctions,Cytoplasmic bodies"				"Cell Junctions"	"Cytoplasmic bodies"	"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavourable (4.41e-4)"	16.4	12.9	13.8	7.0	15.8	0.3	16.8	4.4	8.3	24.8	20.3	7.4	19.7	7.1	21.4	13.6	34.5	14.7	13.2	17.1	10.7	6.3	18.0	15.9	15.2	3.0	7.8	4.3	28.4	26.2	19.0	15.8	14.4	8.8	20.5	15.3	11.7	15.5	17.3	28.3	34.4	14.9	21.1	8.7	3.3	14.2	9.1	9.2	12.8	15.6	14.6	13.4	20.7	29.5	0.0	0.0	9.0	0.1	0.0	0.0	2.1	18.9	46.1	15.7	10.6	11.8	10.1	22.4	8.6	10.4	15.3	17.3	16.8	16.1	0.1	12.5	18.0	13.8	13.3	22.3	19.9	0.1	9.9	0.0	5.8	17.2	15.0	2.0	0.0	12.2	21.4	20.0	15.2	9.6	12.8	6.0	18.4	13.2	21.3	1.4	6.6	16.4	17.0	15.9	8.3	31.8	14.6	8.1	8.1	10.2	14.7	15.9	8.2	2.5	11.0	7.7	22.4	14.3	9.0	4.9	6.0	0.0	8.3	0.0	8.4	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.1	13.8	15.8	4.4	8.3	10.7	6.3	7.8	4.3	8.8	9.2
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ, crumbs cell polarity complex component"	Q8NI35	1	61742406-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4"	"Cell line enhanced"	"Detected in many"		"A-431: 19.3;BEWO: 16.4;RPTEC TERT1: 16.9;RT4: 18.1;SK-BR-3: 16.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA066352, HPA066960, HPA069079"	Approved		Enhanced	"Cell Junctions,Centriolar satellite"				"Cell Junctions, Centriolar satellite"		"HPA066352: , HPA066960: , HPA069079: "	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favourable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	2.6	4.6	3.4	6.3	4.4	1.9	11.6	66.4	3.2	5.7	9.6	2.0	17.9	5.5	4.4	17.7	11.6	5.3	10.3	27.8	2.3	5.1	19.8	7.7	12.5	6.1	4.6	2.0	4.7	17.9	15.2	21.4	2.8	14.2	8.4	7.0	4.4	24.8	24.3	25.4	13.9	15.7	5.2	15.8	2.2	6.3	2.7	3.0	1.3	17.0	11.1	9.6	7.4	7.5	1.8	0.3	9.9	0.2	3.2	4.1	0.8	19.3	3.9	1.3	1.7	0.7	1.9	16.4	1.1	1.5	1.2	1.6	6.7	7.3	0.1	5.2	2.4	11.6	2.8	10.2	2.1	1.9	4.8	0.1	5.6	6.0	1.7	0.0	0.1	0.7	10.9	2.0	4.6	0.6	0.0	0.0	1.0	6.8	0.0	0.0	6.7	1.0	0.0	1.5	2.7	16.9	18.1	3.4	1.1	4.9	16.1	4.2	12.8	0.2	0.1	1.0	2.5	0.1	2.2	0.8	1.4	2.5	0.9	0.0	0.2	0.4	0.1	9.9	1.9	0.1	3.5	1.8	3.1	2.6	0.1	1.5	4.1	2.6	0.9	3.2	0.2	0.3	2.7	0.8	3.4	4.4	66.4	3.2	2.3	5.1	4.6	2.0	14.2	3.0
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.4;RH-30: 46.0;RT4: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: "	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	2.0	3.2	11.9	4.9	11.5	0.4	3.0	1.2	25.3	23.2	18.4	1.7	34.3	3.1	15.3	22.9	13.0	8.9	7.4	16.7	13.4	11.9	2.2	1.2	2.8	1.4	8.0	11.0	4.5	1.1	0.5	0.8	0.5	11.7	9.9	7.3	6.2	1.6	32.2	0.9	10.1	5.3	23.7	5.3	15.3	14.2	1.2	4.4	0.0	3.9	1.3	1.4	20.1	7.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	5.5	7.6	11.5	11.2	0.0	1.4	0.0	0.7	0.3	0.7	9.9	0.0	0.0	0.0	5.7	0.4	14.4	1.3	0.0	16.4	0.0	10.4	0.0	11.9	0.2	0.0	6.7	3.4	0.3	4.1	2.8	0.0	0.0	3.4	0.0	0.0	0.0	3.3	1.5	0.0	46.0	0.0	0.3	24.2	0.3	0.1	0.1	0.4	0.5	0.7	2.5	0.0	9.3	2.4	2.5	0.0	0.0	0.0	0.0	7.2	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.5	1.2	24.9	13.4	11.9	8.0	11.0	11.7	4.4
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 60.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	16.9	3.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.7	15.3	0.0	10.4	0.0	15.1	2.1	13.4	0.0	0.0	4.8	0.1	0.7	15.9	9.5	0.9	0.2	0.0	12.7	0.0	14.7	0.5	3.0	4.8	1.4	4.4	0.0	0.1	9.3	2.9	0.0	7.4	5.0	4.5	8.0	1.9	1.6	0.7	3.5	0.0	7.7	0.2	0.1	0.0	6.8	0.0	4.1	4.0	0.0	0.1	0.0	0.0	0.8	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell line enhanced"	"Detected in many"		"A-431: 37.0;CAPAN-2: 26.0;HaCaT: 50.0;hTCEpi: 32.7;MCF7: 23.3;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: "	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.0	7.2	0.0	0.1	0.0	0.0	15.5	0.3	0.2	0.8	0.4	14.7	26.0	0.0	1.5	0.2	50.0	0.0	18.9	0.1	0.0	9.3	0.0	4.3	10.2	0.1	0.0	0.0	0.1	32.7	0.1	8.0	0.1	11.0	0.2	0.1	23.3	0.1	0.0	0.0	12.5	0.1	0.0	0.1	0.4	7.4	10.6	0.1	10.7	37.9	0.0	13.7	0.1	1.3	0.2	1.3	0.6	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456964-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 111.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"				"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: , HPA070648: "	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favourable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	7.3	3.9	42.7	3.7	42.1	4.2	15.5	14.5	26.6	19.8	7.1	49.9	6.9	7.1	8.3	8.9	10.7	11.8	8.9	12.1	47.7	31.2	34.2	9.7	7.3	3.0	66.9	14.7	8.3	8.7	12.2	6.6	3.4	28.4	7.8	8.1	10.4	19.3	13.1	4.0	9.4	6.4	8.5	111.7	3.2	7.7	5.6	31.6	3.3	18.2	2.4	5.5	9.1	6.9	0.1	0.7	1.0	5.3	0.0	2.1	0.5	16.5	9.2	12.7	14.4	5.9	6.4	12.1	13.8	7.4	20.8	18.1	30.9	15.7	10.6	10.3	16.0	13.4	16.4	13.8	34.9	15.9	8.4	10.0	10.4	25.2	9.9	15.8	2.2	2.8	13.3	14.3	21.9	10.5	13.6	16.9	15.8	18.3	6.9	6.8	13.5	7.0	9.2	19.0	9.1	30.8	12.0	22.2	3.9	9.6	14.4	11.3	17.1	14.5	4.8	12.5	14.0	9.2	17.3	9.7	8.1	7.8	7.3	8.7	12.1	0.0	1.0	0.0	0.4	0.3	0.7	0.0	1.5	0.6	0.4	0.1	1.2	0.4	1.0	0.0	5.3	0.7	2.1	0.5	42.7	42.1	14.5	26.6	47.7	31.2	66.9	14.7	28.4	31.6
PLEKHA6	"KIAA0969, PEPP3"	ENSG00000143850	"Pleckstrin homology domain containing A6"	Q9Y2H5	1	204218851-204377665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.1"	"Cell line enhanced"	"Detected in many"		"A-431: 20.6;BEWO: 33.5;CAPAN-2: 28.0;RT4: 23.2;SK-BR-3: 20.7;T-47d: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028152	Enhanced		Approved	"Vesicles,Cell Junctions"				"Cell Junctions"	Vesicles	"HPA028152: AB_10601048"	"unprognostic (9.81e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.17e-2)"	"prognostic favourable (3.57e-4)"	2.4	4.6	18.2	4.1	27.8	0.4	10.6	60.1	34.5	3.4	23.2	13.4	1.4	18.2	2.6	10.0	13.0	7.4	9.8	11.8	14.2	11.4	20.9	13.9	2.4	0.6	11.5	23.3	2.8	7.6	3.7	17.6	6.3	18.9	9.4	21.9	21.7	5.2	11.2	2.6	2.0	20.8	4.8	19.0	1.9	29.1	2.7	14.2	0.0	2.2	1.3	1.9	7.3	6.1	0.9	1.4	0.1	0.2	0.0	0.4	0.0	20.6	13.0	8.2	0.0	0.1	0.2	33.5	0.7	2.3	0.0	0.1	6.2	28.0	0.1	6.2	0.4	2.3	0.1	2.2	0.1	0.0	1.3	0.0	5.1	8.8	1.2	0.0	0.0	0.3	6.9	0.0	1.8	3.7	0.0	0.0	8.5	9.2	0.0	0.0	2.6	15.9	0.0	0.0	0.0	8.3	23.2	1.7	17.2	9.4	20.7	0.1	19.7	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	18.2	27.8	60.1	34.5	14.2	11.4	11.5	23.3	18.9	14.2
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 55.6;CACO-2: 17.6;CAPAN-2: 9.7;RT4: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"				"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: "	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	55.6	0.1	0.0	0.1	0.1	17.6	9.7	0.1	0.1	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	0.3	0.0	0.0	0.1	0.0	18.7	0.1	0.0	0.4	8.3	0.1	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563811-29567295	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.2;CAPAN-2: 17.2;HaCaT: 19.9;RT4: 15.2;SK-BR-3: 33.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"HPA040996: , HPA048121: "	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favourable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	3.8	0.5	0.7	14.4	0.4	0.0	3.1	0.4	0.8	22.8	58.9	0.8	2.6	24.8	6.8	13.3	0.7	2.9	12.1	1.0	0.6	0.5	12.7	0.5	3.7	0.6	0.4	0.4	4.0	2.0	0.0	2.7	19.0	0.5	2.7	18.5	0.3	4.6	0.9	0.5	0.3	66.1	1.1	1.1	0.4	16.6	1.4	0.4	0.3	1.0	1.0	1.9	7.0	1.9	1.6	0.0	0.0	0.5	0.0	0.0	0.6	7.2	10.3	0.0	0.0	4.0	5.0	13.2	0.3	0.5	0.2	0.1	9.0	17.2	0.0	1.9	2.4	19.9	2.2	0.0	0.0	0.0	1.4	0.5	1.9	9.8	1.3	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.2	1.4	1.6	8.2	0.0	0.0	9.1	11.9	15.2	0.2	0.1	1.0	33.5	0.0	2.4	0.0	8.8	0.2	0.0	0.0	0.4	0.8	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.4	0.8	0.6	0.5	0.4	0.4	0.5	0.4
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070514	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.9;CAPAN-2: 26.2;HaCaT: 23.8;hTCEpi: 23.5;MCF7: 36.3;RT4: 33.0;SK-BR-3: 53.7;T-47d: 50.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"CAB033645: AB_1128883, HPA010872: AB_1079729"	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.4	0.3	0.3	10.9	0.3	0.0	10.8	0.5	0.4	23.6	28.4	0.3	28.1	14.8	4.0	15.9	98.3	9.7	33.3	0.3	0.3	0.3	18.2	1.0	19.1	0.6	0.3	0.2	2.3	27.4	8.6	9.5	19.1	0.3	13.3	16.2	0.4	44.1	26.8	0.4	48.0	43.0	2.1	0.4	0.3	16.2	1.1	0.2	3.7	36.1	74.6	60.9	13.0	31.8	0.1	0.0	0.0	0.0	0.0	3.4	0.8	19.7	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	19.3	26.2	0.0	0.0	0.0	23.8	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	33.0	2.9	0.0	0.0	53.7	0.0	50.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	2.8	0.8	0.0	0.0	3.4	2.9	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.3	0.5	0.4	0.3	0.3	0.3	0.2	0.3	0.2
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102482445-102517781	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 47.4"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 6.2;monocytes: 3.7"									HPA043010	Uncertain		Uncertain	"Vesicles,Cell Junctions"				"Cell Junctions"	Vesicles	"HPA043010: "	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	2.9	1.1	2.3	1.4	1.2	0.0	2.1	0.5	4.4	3.2	2.4			2.5	4.1	0.0	0.6	1.5	1.3	0.5	1.8	2.0	0.9	0.1	0.8	1.3	1.1		2.2	0.9	0.0	1.1	1.7		1.5	0.0		0.7	3.7	47.4	1.8	3.0	0.5	0.5	1.9	0.8	0.2			0.3		0.2	1.4	2.3	0.1	6.2	0.0	3.7	0.0	0.2	1.8	0.2	0.9	3.2	0.2	0.5	1.9	0.1	5.7	3.0	1.2	2.9	0.2	0.4	2.2	6.4	6.5	7.6	0.0	0.0	0.0	0.2	0.7	0.3	1.7	0.5	0.0	0.0	0.2	2.1	0.3	0.0	0.0	0.8	0.6	8.1	0.7	2.1	0.0	1.1	0.0	0.9	2.3	1.1	3.6	0.0	0.8	2.2	11.8	0.9	0.2	0.2	0.2	1.5	1.0	16.5	14.1	1.3	0.5	2.7	1.8	0.2	1.9	0.4	2.6	0.0	3.7	0.0	0.2	3.7	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.6	3.9	0.0	1.8										
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	Autophagy	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 48.8;NB-4: 38.4;THP-1: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"				"Cell Junctions"	"Nucleoli fibrillar center"	"HPA056384: , HPA069984: "	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	7.0	4.8	6.0	19.0	7.5	36.7	12.7	2.5	5.0	3.3	3.5	6.8	1.9	5.5	2.9	2.9	4.4	4.1	4.5	5.1	5.4	4.9	4.0	7.2	10.4	27.2	9.1	2.6	2.7	3.9	0.8	2.6	5.6	5.7	3.9	1.8	2.2	6.1	2.2	1.6	4.3	10.6	3.2	7.1	43.1	5.7	2.8	7.2	15.2	3.7	1.2	19.5	6.1	3.6	17.3	29.9	95.0	55.5	9.1	13.8	22.0	4.8	7.4	2.1	3.8	0.9	1.6	3.6	3.0	2.1	6.4	2.6	10.9	6.7	8.5	8.5	1.9	4.7	2.1	3.9	1.5	4.1	4.1	12.1	3.8	4.4	1.2	24.7	48.8	1.0	2.4	2.7	0.9	4.1	4.6	4.5	1.9	8.6	18.2	38.4	2.2	9.4	15.3	1.2	6.1	1.8	2.4	4.1	3.8	3.1	1.9	4.0	2.6	32.6	4.3	6.0	3.0	1.0	2.9	2.8	2.2	10.3	3.3	18.9	3.9	33.1	35.5	95.0	13.4	50.4	13.8	17.3	12.7	12.7	29.9	17.1	8.9	9.2	79.6	9.1	55.5	17.1	13.5	22.0	6.0	7.5	2.5	5.0	5.4	4.9	9.1	2.6	5.7	7.2
RSC1A1	RS1	ENSG00000215695	"Regulator of solute carriers 1"	Q92681	1	15659869-15661722	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027813, HPA028676"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA027813: AB_10600308, HPA028676: AB_10600895"																		3.0	0.9	0.3	1.7	0.4	2.8	2.6	0.1	0.6	2.2	0.6			0.0	1.2	0.0	3.5	1.2	1.1	2.9	0.3	0.5	4.0	7.7	2.7	2.0	0.4		4.6	0.2	2.1	1.3	2.3		3.9	1.3		0.1	0.8	0.6	2.1	0.6	3.0	0.8	0.1	0.6	4.7			1.7		3.2	1.1	2.2	1.1	2.8	0.5	3.5	1.7	2.3	1.5	3.3	3.8	4.7	3.1	5.9	4.1	6.3	2.8	4.6	7.7	7.3	6.3	5.4	7.3	2.7	6.2	2.2	12.3	3.9	9.6	4.8	3.1	6.8	7.6	6.7	1.3	10.0	3.5	3.2	0.0	13.3	7.4	4.8	18.6	6.9	5.6	3.3	5.2	0.0	5.1	2.2	4.5	6.6	3.0	1.8	6.1	3.8	1.5	5.2	2.3	4.5	3.3	0.9	4.7	4.0	7.3	3.5	2.0	2.1	3.9	12.7	1.5	2.7	2.8	0.0	1.2	0.5	0.4	3.5	1.4	1.1	0.5	2.3	2.8	0.2	0.6	0.5	0.0	1.7	0.1	0.7	2.3	1.5										
SAMD4A	"DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA"	ENSG00000020577	"Sterile alpha motif domain containing 4A"	Q9UPU9	14	54567097-54793315	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.7;testis: 44.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.9;non-classical monocyte: 3.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043061, HPA065309"	Approved		Approved	"Cell Junctions,Cytosol"				"Cell Junctions"	Cytosol	"HPA043061: , HPA065309: "	"unprognostic (1.46e-1)"	"unprognostic (8.10e-3)"	"unprognostic (9.66e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	7.5	2.9	7.8	9.0	6.0	0.5	4.0	5.6	7.0	8.9	10.1	8.0	3.0	2.3	11.1	5.5	5.4	4.2	6.5	28.2	5.5	7.3	2.5	7.6	6.4	2.9	10.6	5.2	2.1	4.1	4.8	2.0	6.0	10.8	7.7	3.3	3.4	2.4	6.3	48.7	2.6	3.3	23.8	26.5	4.6	3.9	44.6	6.1	0.7	2.4	1.3	4.8	15.9	5.8	0.9	2.6	0.0	3.9	0.0	0.4	0.8	16.7	1.7	3.3	1.7	7.1	11.3	6.2	14.6	21.0	11.6	11.9	17.3	4.0	1.0	7.5	20.2	11.7	3.2	7.3	16.4	9.6	1.6	0.0	2.0	3.5	4.0	0.0	0.1	6.3	2.5	8.3	12.4	9.0	1.3	0.0	5.4	1.1	0.2	0.0	1.6	4.1	0.5	6.7	0.0	5.4	5.4	0.5	5.5	2.3	2.8	7.6	11.1	0.2	18.3	13.8	22.8	3.4	4.5	0.1	0.0	0.0	3.9	0.3	4.4	0.0	2.3	0.0	0.0	3.9	0.0	0.3	0.0	0.0	2.6	0.9	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.8	7.8	6.0	5.6	5.7	5.5	7.3	10.6	5.2	10.8	6.1
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762799-31764851	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"retina: 8.8;skin 1: 14.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA071699			Approved	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"HPA071699: "	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	0.8	0.3	0.7	1.6	1.0	4.8	1.8	0.7	1.3	2.0	1.0	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0.0	0.5	0.2	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.5	0.4	0.8	0.8	0.5	0.2	0.2	0.0	2.9	1.0	0.8	0.1	0.2	1.7	0.0	0.8	0.1	0.0	3.2	3.9	7.7	1.1	0.2	0.4	0.1	0.2	0.0	1.2	1.4	0.5	0.5	1.2	0.0	3.9	2.9	2.4	0.0	0.9	0.4	0.9	0.0	0.6	0.7	1.2	0.6	0.3	0.7	0.5	0.3	0.0	0.3	0.1	3.1	0.0	0.3	2.2	2.1	2.0	0.2	2.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.7	1.0	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: "	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavourable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavourable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	19.9	4.7	14.4	12.3	10.0	8.5	47.4	10.8	8.2	8.5	13.7	15.8	11.6	21.9	15.1	9.7	19.1	20.1	20.1	16.1	13.7	20.4	18.0	12.8	18.3	17.7	22.9	1.9	11.9	24.6	12.6	24.7	20.5	22.7	14.6	9.5	3.9	13.5	11.5	46.6	15.0	12.0	22.8	15.1	10.5	0.3	16.0	8.4	20.9	0.6	16.0	0.9	8.7	13.8	8.2	14.5	16.1	15.9	7.7	6.7	22.1	23.8	14.5	10.1	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 28.8;HEK 293: 12.4;RPMI-8226: 23.8"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.3	0.0	0.1	0.5	0.7	5.0	0.2	4.0	0.9	0.1	0.0	28.8	0.0	0.5	0.0	12.4	4.7	0.3	4.7	0.0	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	2.0	6.1	0.6	8.9	1.8	3.5	4.3	23.8	0.0	0.4	6.7	2.1	0.1	0.6	1.1	1.1	0.7	0.0	0.1	1.1	0.3	1.6	1.9	0.0	1.0	0.2	3.7	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650761-59736002	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 58.0;kidney: 70.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.8;U-251 MG: 8.3;U-937: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA049286: "	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favourable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	0.7	58.0	5.7	2.0	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10.0	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3.0	6.0	14.3	2.4	3.4	6.5	0.0	11.2	4.4	3.1	0.9	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	4.2	5.5	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.7	8.7	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.1	1.8	0.0	0.4	0.1	0.0	2.3	0.3	6.1	0.1	0.4	3.3	2.3	0.0	16.4	7.5	2.7	0.2	5.7	0.0	0.2	2.8	7.8	0.1	0.3	0.0	2.7	3.6	2.6	0.4	0.9	0.1	8.3	0.0	0.0	0.0	0.0	14.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.7	4.6	9.9	4.3	10.0	2.6	6.7	5.5	8.2	6.5
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"intestine: 36.5;kidney: 32.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 8.9;U-266/70: 6.5"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Low region specificity"	"Detected in single"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	0.4	0.0	0.3	2.3	0.3	0.0	0.5	0.3	0.5	0.8	14.9	0.3	0.3	5.3	1.1	0.3	0.9	0.5	0.3	0.3	0.3	0.0	32.4	3.1	0.7	0.3	0.3	0.3	1.0	0.4	0.5	0.3	0.5	0.3	1.4	0.8	0.3	0.4	0.3	0.3	1.1	36.5	0.3	0.3	0.4	0.5	0.3	0.3	0.3	1.3	0.3	0.4	0.6	1.3	0.8	0.0	0.0	0.8	0.0	0.5	0.0	0.9	0.4	0.2	1.1	3.9	2.2	0.8	2.2	0.6	0.4	1.3	2.3	1.6	0.5	0.8	1.5	3.2	0.7	0.3	0.6	1.8	1.8	2.0	1.9	0.1	0.7	0.2	0.9	0.7	8.9	0.9	2.9	1.2	0.3	0.9	0.6	0.3	0.1	1.0	0.0	0.2	0.5	0.5	0.8	3.1	3.7	0.5	1.0	0.2	0.0	2.3	0.9	1.1	2.6	2.1	1.4	2.2	0.7	6.5	0.3	2.9	0.6	0.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.3
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA042960: , HPA071184: "	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favourable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	4.3	7.8	8.5	6.1	15.3	3.5	6.2	22.9	17.0	4.1	4.9	6.4	17.2	3.9	7.7	9.0	2.8	5.0	5.2	8.5	11.0	13.4	19.5	4.9	4.5	7.1	9.5	10.9	6.6	28.8	18.6	14.0	21.0	9.7	7.6	6.0	10.4	6.1	11.4	13.6	4.2	4.8	10.4	9.6	5.3	6.1	4.5	6.2	1.6	9.2	2.4	6.4	4.5	5.3	2.2	4.6	1.5	1.1	1.2	1.6	0.3	2.6	1.3	1.7	7.6	1.7	3.5	0.8	1.6	2.0	1.8	1.3	1.8	1.8	3.4	0.9	2.2	2.2	3.2	0.9	1.0	2.4	2.9	1.7	2.8	2.6	2.5	1.6	1.8	1.3	3.2	2.7	2.3	0.7	0.7	7.6	1.0	2.8	0.3	0.7	2.5	2.1	4.6	0.2	3.8	5.6	0.7	4.1	2.4	0.8	12.1	2.7	6.3	0.8	0.5	0.7	1.2	0.7	0.8	7.2	2.0	3.4	1.5	1.2	1.8	1.5	0.4	0.9	0.9	1.1	0.7	2.1	0.8	0.8	0.2	2.2	1.6	1.1	1.2	1.2	0.7	4.6	0.2	0.3	8.5	15.3	22.9	17.0	11.0	13.4	9.5	10.9	9.7	6.2
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.6;CAPAN-2: 10.4;HaCaT: 7.9;HEK 293: 6.5;U-2 OS: 11.3"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: "	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	3.0	1.0	2.6	0.0	2.0	1.1	0.2	1.8	7.6	1.0	4.2	0.0	10.4	0.4	1.6	0.1	7.9	0.0	0.8	1.5	0.0	6.5	0.0	0.9	0.1	0.3	0.0	0.0	1.5	0.7	0.8	0.2	0.6	0.6	0.9	0.2	0.9	0.1	0.1	2.3	0.7	0.0	1.3	2.8	2.3	1.0	0.3	0.8	0.1	2.4	0.0	0.1	0.0	0.1	0.2	11.3	0.2	1.0	3.9	3.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644559	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 61.1;SK-BR-3: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"			78000	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: "	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favourable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	29.3	14.2	25.1	21.4	28.3	23.4	31.6	24.2	33.9	24.7	23.0	40.7	21.7	10.5	21.0	17.3	31.8	24.8	24.9	29.1	21.2	17.9	29.4	9.1	39.4	46.7	26.1	18.4	14.2	16.5	21.6	8.6	114.9	31.8	19.9	20.3	36.6	22.1	28.8	51.6	29.0	19.1	19.3	37.5	49.4	44.0	51.6	21.2	30.4	26.9	26.4	39.2	29.0	26.3	19.0	17.8	86.0	45.9	13.1	21.8	22.8	61.1	1.5	13.7	8.2	20.8	12.8	39.2	13.3	32.8	22.0	26.0	13.7	29.3	12.4	17.9	36.8	47.3	2.0	10.2	14.2	0.3	1.7	7.9	7.7	0.5	23.0	0.1	6.6	13.9	13.6	8.3	7.2	16.8	3.7	2.1	33.3	45.0	6.5	5.9	4.8	5.5	13.9	19.5	0.5	7.1	32.5	1.3	8.2	10.5	58.9	1.5	22.9	0.6	15.3	9.9	3.6	11.7	3.3	0.7	1.3	12.2	2.4	5.5	11.0	22.9	7.2	39.3	21.8	19.6	17.2	17.7	15.1	16.5	3.7	19.0	16.5	16.8	86.0	13.1	45.9	17.8	16.5	22.8	25.1	28.3	24.2	33.9	21.2	17.9	26.1	18.4	31.8	21.2
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 76.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 33.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favourable (5.22e-5)"	"prognostic unfavourable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.2	25.9	5.7	18.0	16.5	46.4	8.1	11.1	12.2	11.3	9.5	8.7	3.6	8.5	14.5	4.4	7.0	7.0	14.5	23.2	5.6	4.6	16.6	2.3	18.6	12.9	18.0	7.6	31.3	2.8	3.8	9.6	18.0	13.3	5.0	4.1	76.4	15.7	7.7	26.6	16.8	22.2	8.2	11.1	20.3	14.0	4.0	12.6	6.2	10.4	11.3	11.2	8.8	6.1	1.6	1.9	33.2	6.9	0.7	3.9	2.3	4.6	17.1	6.2	4.7	8.0	2.5	12.7	6.9	27.5	8.2	6.1	6.2	7.9	13.4	6.4	10.9	3.7	4.2	5.7	7.4	1.5	5.2	12.7	22.5	9.3	0.2	3.4	27.5	1.3	1.7	7.5	1.9	8.9	7.1	2.7	7.2	4.9	9.7	6.7	9.5	5.0	6.9	7.3	20.9	45.1	9.6	11.4	4.1	5.2	2.8	1.5	10.6	1.9	22.5	10.5	5.6	2.6	5.0	3.0	3.4	4.9	24.5	6.8	32.1	2.5	5.1	5.0	1.3	4.2	0.7	1.6	1.4	1.7	1.9	0.9	0.2	0.3	33.2	0.7	6.9	0.7	3.9	2.3	5.7	16.5	11.1	12.2	5.6	4.6	18.0	7.6	13.3	12.6
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 66.3;RT4: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA009277: "	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (2.65e-7)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.1	0.0	0.1	11.1	0.0	6.8	0.5	0.6	3.3	0.0	0.0	2.3	0.0	0.0	7.3	1.7	2.3	0.0	3.8	0.0	8.0	7.0	66.3	3.0	0.0	8.9	1.4	8.6	8.2	3.1	0.0	0.0	7.7	10.7	0.3	3.5	3.7	0.9	0.0	5.1	5.3	0.8	17.0	0.1	1.3	0.5	0.2	3.1	0.0	0.3	7.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"HPA047008: "	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.3	7.9	8.8	6.3	13.3	5.3	5.5	16.5	24.5	5.6	5.0	5.2	0.4	2.0	8.5	4.2	4.7	5.9	9.8	5.5	8.9	12.5	1.9	45.6	3.3	7.2	10.3	13.4	8.0	2.4	1.2	8.8	5.2	20.8	5.6	3.9	8.3	2.1	6.7	4.5	3.7	3.0	9.8	9.8	4.6	5.7	4.8	4.7	2.5	2.6	1.8	6.9	5.5	8.5	5.6	1.7	0.0	0.1	12.2	6.3	1.8	2.6	1.3	3.1	6.4	15.5	13.0	0.0	11.9	4.7	2.0	1.8	1.3	1.7	16.8	2.1	13.8	0.8	7.0	5.0	2.8	14.7	4.9	16.8	4.2	12.1	8.3	11.7	5.3	11.4	6.7	4.2	14.5	8.5	5.6	12.3	6.2	1.0	9.4	7.2	2.3	3.8	0.0	3.4	7.3	5.7	1.0	10.7	9.7	5.4	1.4	3.5	1.4	7.8	10.5	4.4	2.7	6.9	4.1	10.5	7.6	12.2	5.3	10.3	1.7	0.0	0.1	0.0	5.1	0.0	6.3	5.6	5.6	4.5	0.9	3.6	3.4	4.2	0.0	12.2	0.1	1.7	2.4	1.8	8.8	13.3	16.5	21.2	8.9	12.5	10.3	13.4	20.8	4.7
SNX32	"FLJ30934, SNX6B"	ENSG00000172803	"Sorting nexin 32"	Q86XE0	11	65833641-65856896	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 16.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.0;HSkMC: 7.8;REH: 2.5;SH-SY5Y: 3.0;U-266/70: 9.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041775	Uncertain		Uncertain	"Cell Junctions,Focal adhesion sites"				"Cell Junctions, Focal adhesion sites"		"HPA041775: AB_10797268"	"unprognostic (6.74e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.00e-1)"	"unprognostic (9.28e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.36e-2)"	0.8	1.0	9.0	1.1	16.6	1.3	1.3	3.5	16.1	1.6	2.2	1.6	0.0	3.4	2.0	1.3	0.9	2.5	2.8	0.9	10.2	5.0	0.9	0.7	0.8	1.0	3.6	10.9	1.3	0.8	0.8	0.3	0.9	3.4	0.8	1.9	0.1	0.7	0.9	0.6	1.1	1.5	2.0	1.8	0.9	0.9	3.5	3.7	0.0	0.7	0.0	1.3	1.0	0.2	1.0	1.2	0.2	0.3	0.1	3.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.6	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.1	0.0	2.5	0.0	2.2	0.1	0.0	0.0	3.0	0.0	0.0	1.7	0.0	0.4	0.0	0.3	0.0	0.0	0.0	9.1	1.5	0.0	0.7	0.0	0.3	0.0	0.1	0.0	1.2	0.3	3.0	0.3	1.6	1.2	1.2	1.0	1.4	0.6	0.2	0.1	0.0	0.7	1.2	0.4	9.0	16.6	3.5	15.4	10.2	5.0	3.6	10.9	3.4	3.7
SPERT	"CBY2, NURIT"	ENSG00000174015	"Spermatid associated"	Q8NA61	13	45702311-45714559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 66.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.7;HDLM-2: 3.4;hTCEpi: 1.2;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039359, HPA040046"	Enhanced		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA039359: AB_10794088, HPA040046: AB_10796117"	"unprognostic (2.86e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.19e-4)"		"unprognostic (8.52e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-1)"		"unprognostic (2.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.15e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.7	0.8	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66685248-66729226	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7;skin 1: 36.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 19.9;NTERA-2: 23.1;SCLC-21H: 23.5;T-47d: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Cell Junctions,Cytosol"			4800000	"Cell Junctions, Cytosol"		"CAB009844: AB_2194521, HPA039293: , HPA043529: "	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	0.8	4.9	26.2	1.0	38.3	1.7	4.5	29.6	46.7	9.6	0.9	2.0	0.0	1.0	1.1	1.2	12.7	2.6	1.2	0.7	19.7	8.2	12.7	7.1	0.9	0.5	6.5	24.7	0.8	8.3	12.2	3.9	0.7	14.4	6.8	0.7	1.7	13.4	3.1	0.7	36.9	0.9	1.2	1.9	0.9	1.2	18.9	6.2	0.0	0.5	0.1	3.3	1.1	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.4	3.3	1.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.1	8.0	0.0	1.7	0.0	7.7	11.7	1.1	0.0	0.0	4.6	0.0	19.9	1.1	0.3	3.3	0.3	0.1	5.4	0.0	3.5	2.9	3.2	0.0	0.0	12.5	2.6	1.5	23.1	10.3	10.7	1.3	6.6	4.4	1.1	23.5	13.8	6.5	16.4	1.5	18.7	0.9	0.6	0.0	4.1	0.6	5.1	0.3	1.2	6.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.2	38.3	29.6	46.7	19.7	8.2	6.5	24.7	14.4	6.2
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease mutation, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 33.4"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: "	"prognostic unfavourable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	6.0	5.8	11.0	2.9	9.6	3.7	4.9	15.8	17.7	4.2	3.5	2.8	6.7	3.8	3.3	5.0	2.2	4.3	3.5	4.9	9.0	5.4	7.6	6.6	6.4	3.0	3.8	12.2	2.1	16.6	5.2	5.6	3.6	7.5	4.5	1.9	5.4	33.4	6.4	6.1	3.5	2.8	3.1	3.7	3.4	3.8	2.4	4.5	0.8	5.5	1.0	2.3	4.0	2.9	0.2	1.3	0.0	0.9	0.2	2.2	1.0	2.6	5.0	3.3	6.8	4.0	4.0	2.9	4.7	2.4	3.1	2.6	4.7	2.2	6.5	4.3	3.6	4.7	5.2	1.4	2.2	7.1	6.2	5.9	6.5	4.0	2.4	4.2	2.5	1.5	2.1	2.7	1.1	3.8	7.1	3.6	2.8	4.6	2.9	8.5	3.0	3.3	15.1	6.4	4.5	2.2	1.7	26.5	6.4	3.1	11.6	1.9	3.7	3.8	4.0	6.1	6.6	5.9	4.6	2.4	2.1	8.1	2.6	6.2	5.4	0.0	0.7	0.0	2.2	0.8	0.7	0.2	0.5	0.7	1.3	0.1	0.5	0.3	0.0	0.2	0.9	0.6	0.0	1.0	11.0	9.6	15.8	12.4	9.0	5.4	3.8	12.2	7.5	4.5
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.0;HUVEC TERT2: 9.6;TIME: 15.2;U-87 MG: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavourable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	3.1	2.7	1.5	5.8	2.7	5.8	8.4	2.0	4.0	5.2	1.8	0.6	2.0	1.8	6.1	2.1	13.1	2.2	3.5	3.5	2.3	1.9	3.1	6.4	7.1	12.4	1.6	1.2	4.2	3.2	2.1	3.8	8.1	2.8	5.5	1.6	1.7	5.7	9.2	2.1	6.7	3.5	5.0	4.7	4.0	3.1	2.2	2.0	7.3	2.3	7.6	7.0	8.0	12.1	2.6	1.0	7.0	0.4	3.5	6.5	1.3	4.7	0.3	0.3	0.3	0.9	0.9	1.9	1.5	2.6	0.6	1.9	0.2	0.5	0.3	2.0	1.2	0.9	0.1	2.4	2.1	9.0	0.5	0.8	0.7	0.2	1.1	0.3	0.6	2.5	1.1	0.3	0.9	9.6	2.6	4.7	4.1	0.8	0.6	0.9	0.3	2.4	0.4	2.0	2.2	0.0	1.9	0.3	0.2	0.5	3.4	0.3	1.8	0.3	15.2	1.4	1.0	5.2	0.4	7.5	2.4	0.2	13.2	0.5	2.7	7.0	0.4	0.4	4.0	0.4	4.2	2.6	6.5	4.1	0.3	2.5	5.8	4.6	1.6	3.5	0.3	1.0	6.2	1.3	1.5	2.7	2.0	4.0	2.3	1.9	1.6	1.2	2.8	2.0
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	4	"blood: 2.2;parathyroid gland: 1.9;placenta: 1.3"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;U-266/70: 3.9;U-266/84: 1.8"									"Cell type enhanced"	"Detected in some"		"basophil: 2.2;T-reg: 1.8"	"Low lineage specificity"	"Detected in many"											"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.9		1.3		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.1	0.0			0.0		0.0	0.0		0.6	0.0	2.2	0.0	0.0	1.8	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.1										
TEDC2	"C16orf59, FLJ13909"	ENSG00000162062	"Tubulin epsilon and delta complex 2"	Q7L2K0	16	2460080-2464963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3;testis: 12.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051394, HPA055389"	Approved		Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"HPA051394: , HPA055389: "	"unprognostic (3.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.38e-3)"	"prognostic unfavourable (2.43e-5)"	"prognostic unfavourable (7.58e-4)"	"unprognostic (4.04e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.03e-1)"	0.8	1.8	2.3	6.2	4.1	9.3	1.1	2.8	4.6	1.2	2.6	0.8	0.0	4.3	1.2	1.4	4.5	1.2	1.4	1.3	2.3	2.7	2.2	1.7	1.0	5.6	2.1	1.9	1.0	1.9	0.3	2.4	3.8	2.0	1.3	2.2	1.0	1.3	0.8	1.0	2.6	3.8	1.1	1.4	2.5	2.2	12.5	0.8	15.3	0.9	4.2	3.9	0.6	2.2	1.2	1.4	0.0	1.0	0.0	2.1	0.7	5.2	16.6	9.5	11.1	0.1	0.6	9.6	4.2	2.5	6.8	6.6	11.4	4.3	7.3	6.9	1.7	8.1	6.9	4.2	1.6	8.1	9.2	6.5	11.7	11.7	0.2	6.3	8.9	0.6	0.5	6.0	1.6	3.1	11.2	2.8	2.3	10.0	11.1	11.8	21.1	6.0	27.1	8.2	16.4	1.4	2.2	9.0	14.8	4.8	5.1	3.6	7.6	7.4	1.1	7.2	10.5	6.9	9.4	6.2	10.1	14.6	3.7	6.4	9.8	0.0	0.0	0.0	0.1	0.1	0.0	0.6	2.1	0.0	0.3	1.2	0.7	1.3	0.0	0.0	1.0	1.4	1.9	0.7	2.3	4.1	2.8	4.6	2.3	2.7	2.1	1.9	2.0	0.8
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708109-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 22.3;CAPAN-2: 22.4;MCF7: 9.9;SK-BR-3: 13.0;T-47d: 27.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: , HPA053337: "	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favourable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favourable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.3	8.4	0.4	0.0	3.6	0.2	0.3	3.3	34.9	0.7	15.0	23.0	0.7	5.0	16.0	7.9	22.8	0.6	0.5	0.1	4.4	8.0	10.1	0.6	0.2	0.2	2.2	5.9	2.0	1.6	2.7	1.1	2.6	7.7	1.6	26.1	20.5	0.4	4.3	47.0	0.6	0.2	0.4	15.2	1.4	0.2	0.6	5.5	2.6	8.3	4.5	3.4	1.0	0.0	0.0	0.0	0.0	6.2	1.7	0.1	3.3	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	6.6	22.4	4.0	0.6	0.0	5.2	0.3	0.0	0.0	0.2	0.1	0.0	0.5	1.6	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.0	0.1	0.4	0.1	0.0	0.0	2.9	0.7	3.5	0.1	0.1	0.8	13.0	0.0	27.5	0.1	0.0	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	6.2	0.7	4.8	3.8	0.0	1.0	5.3	1.9	0.0	0.0	0.0	0.0	5.5	1.7	0.3	0.4	0.2	0.3	0.5	0.1	0.2	0.2	1.1	0.2
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791355-136793257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"				Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: "	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	10.0	15.5	15.7	23.4	15.3	15.5	22.9	11.6	28.3	17.2	54.4	21.0	22.4	21.9	9.4	31.1	35.5	22.6	27.9	22.8	15.2	12.2	38.5	43.4	14.4	23.0	19.9	19.3	13.8	46.3	20.6	23.1	31.7	22.0	49.0	51.4	12.5	32.5	27.5	13.5	22.0	25.6	10.5	19.1	14.1	23.3	16.5	13.8	16.3	28.6	26.0	15.2	16.4	16.3	11.1	42.7	9.0	19.4	12.4	11.3	12.2	16.0	11.6	10.4	6.5	13.1	10.6	22.5	9.1	14.2	11.2	9.0	15.3	14.6	15.4	14.2	9.8	23.9	4.4	26.5	3.6	11.2	8.0	8.6	6.5	17.1	19.2	8.9	10.8	10.1	45.5	8.6	24.4	16.7	8.5	8.3	14.7	32.7	12.2	6.9	5.0	13.1	10.2	11.0	45.3	25.5	9.0	17.5	7.9	9.8	37.2	10.2	66.4	8.7	11.4	8.0	6.4	14.6	5.9	5.4	8.4	8.2	12.1	12.9	11.5	6.5	13.8	9.0	11.3	19.4	10.2	8.7	7.9	8.1	11.2	11.1	10.9	10.0	3.3	12.4	16.0	42.7	7.5	12.2	15.7	15.3	11.6	28.3	15.2	12.2	19.9	19.3	22.0	13.8
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 69.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favourable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	15.0	8.6	9.2	6.1	10.9	11.1	9.2	2.6	6.8	3.9	17.0	6.0	36.3	14.5	4.5	4.1	10.5	5.5	8.8	14.7	6.6	5.9	8.4	1.7	35.8	7.6	4.6	3.5	11.9	17.2	11.1	8.7	6.6	7.0	6.2	14.8	18.7	7.6	69.7	32.0	15.2	33.1	4.6	2.9	6.9	9.9	2.2	5.1	4.5	11.4	6.0	5.8	5.0	5.1	0.4	1.4	25.9	1.7	1.1	0.9	0.8	4.7	10.9	9.0	5.8	11.1	8.2	5.5	2.4	5.6	5.1	3.3	8.5	7.5	3.8	16.3	3.7	7.0	7.7	12.6	5.0	10.5	5.3	25.9	5.9	3.5	6.6	11.4	37.1	11.3	22.3	9.1	12.7	9.9	8.0	4.6	9.0	9.5	11.9	14.5	8.0	7.9	5.5	6.9	3.2	8.1	5.0	8.4	9.4	15.3	15.1	7.0	4.4	11.4	22.0	4.3	3.2	5.0	3.4	2.7	3.4	3.1	11.3	14.3	11.5	25.9	1.7	7.2	0.3	1.5	0.9	0.1	0.4	0.3	1.4	0.4	0.2	0.3	8.8	1.1	0.9	0.2	0.5	0.8	9.2	10.9	2.6	6.8	6.6	5.9	4.6	3.5	7.0	5.1
TMEM251	"C14orf109, DKFZP564F1123"	ENSG00000153485	"Transmembrane protein 251"	Q8N6I4	14	93184951-93187089	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048559	Uncertain		Approved	"Golgi apparatus,Cell Junctions"				"Cell Junctions"	"Golgi apparatus"	"HPA048559: "	"unprognostic (1.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavourable (6.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.99e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.58e-1)"	"prognostic favourable (1.10e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.17e-2)"	15.8	19.5	12.2	10.7	14.3	3.9	23.1	11.5	14.2	21.9	19.6	11.4	19.6	15.5	13.0	26.2	10.8	15.8	11.5	23.2	12.2	12.8	25.0	14.4	24.1	19.1	19.0	11.1	12.4	23.6	16.4	17.2	12.5	15.8	26.1	19.5	18.3	18.7	18.5	22.6	10.4	17.9	11.5	17.3	13.3	16.5	8.7	15.1	14.2	19.4	11.0	11.7	13.3	11.8	6.0	8.7	13.7	12.7	5.4	6.6	4.4	7.0	7.5	10.1	10.6	11.7	4.6	6.8	4.9	5.8	8.6	11.1	5.3	7.4	8.0	10.0	4.7	9.5	10.9	8.0	11.7	7.3	8.5	6.8	5.6	10.6	11.1	9.5	11.0	6.1	9.2	6.9	11.1	8.6	5.6	7.9	6.9	33.7	6.8	7.7	5.9	8.1	4.1	10.1	7.1	10.7	14.3	9.7	9.1	7.4	4.1	29.0	11.2	6.9	3.8	4.3	7.0	9.0	6.2	10.5	12.5	8.2	8.1	4.0	6.5	4.8	10.8	13.7	4.7	9.7	3.1	5.3	5.5	5.3	8.7	6.0	6.1	6.6	10.7	5.4	12.7	7.6	4.4	4.4	12.2	14.3	11.5	14.2	12.2	12.8	19.0	11.1	15.8	15.1
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464551-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.6;pancreas: 64.5;prostate: 68.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.6;MCF7: 6.3;RT4: 35.2;SK-BR-3: 7.2;T-47d: 5.4"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA034493, HPA035787"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"			"Cell Junctions"	Nucleoplasm	"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favourable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.2	0.1	0.2	15.5	0.4	0.0	6.1	0.2	0.5	1.3	38.7	0.4	24.4	17.5	0.5	0.9	10.7	2.2	17.3	0.2	0.3	0.1	19.4	18.4	20.7	0.2	0.2	0.2	0.7	64.5	0.0	1.3	1.0	0.4	68.2	18.5	0.3	52.3	35.7	0.2	2.1	75.6	0.9	0.2	0.3	36.7	0.8	0.3	0.5	19.9	3.9	10.2	5.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.6	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.5	1.3	0.0	0.0	0.0	1.4	0.6	35.2	0.0	0.4	0.0	7.2	0.1	5.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.5	0.3	0.1	0.2	0.2	0.4	0.3
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779899-223845972	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: "	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	10.0	8.3	26.5	17.2	28.7	38.8	20.8	9.3	17.9	10.9	12.0	12.6	8.1	7.9	11.9	9.8	15.9	9.4	17.4	10.9	17.3	14.7	10.1	13.9	21.4	18.6	18.7	8.6	15.5	13.0	16.4	8.3	8.2	12.9	9.6	9.5	17.7	10.2	8.1	12.0	9.9	9.5	12.2	13.0	10.6	9.7	10.2	14.9	17.3	22.1	7.4	11.7	11.8	14.8	2.2	2.9	6.7	2.7	7.2	4.0	2.0	15.3	7.7	21.0	13.2	7.5	7.3	13.4	9.9	14.1	14.5	12.5	15.9	9.3	0.0	8.7	8.2	10.5	16.3	5.9	19.5	29.6	16.1	20.3	7.5	5.4	15.2	16.7	14.3	8.7	6.5	13.3	13.7	8.5	25.7	15.4	12.0	4.4	12.7	10.3	18.1	7.5	16.9	21.9	1.7	13.0	9.7	18.2	23.5	10.9	13.6	14.3	7.7	23.0	9.9	14.9	10.5	16.0	18.5	7.6	7.9	12.7	9.0	11.3	16.9	6.7	2.7	1.6	2.3	2.6	2.8	2.2	2.6	4.0	2.9	1.9	2.7	1.9	3.2	7.2	2.0	1.7	1.6	2.0	26.5	28.7	9.3	17.9	17.3	14.7	18.7	8.6	12.9	14.9
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937235-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA047032: , HPA050408: "	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	10.5	12.9	10.5	11.3	12.1	20.6	8.5	15.0	10.5	7.3	7.4	5.7	47.8	5.1	9.1	7.9	11.9	7.9	5.6	13.2	8.4	9.5	10.2	10.1	7.2	13.2	8.3	11.8	9.6	9.6	9.8	13.9	9.4	13.6	7.2	8.2	5.1	8.2	33.9	24.4	9.9	8.6	8.0	8.2	12.2	7.5	15.5	7.9	10.3	8.7	10.6	12.7	8.8	7.9	9.2	17.8	5.9	8.7	13.9	11.6	7.1	25.2	12.5	8.4	12.9	4.8	6.2	11.7	12.2	6.2	11.9	10.0	16.4	11.2	30.1	6.4	6.7	19.4	16.8	19.3	20.0	6.2	11.7	24.8	5.8	14.7	9.3	22.7	6.5	6.1	10.2	21.2	16.0	5.0	14.9	9.4	13.7	7.0	23.6	12.4	19.0	15.7	15.7	16.7	16.5	8.1	16.1	16.4	25.4	14.8	19.2	19.5	10.2	11.1	4.9	14.2	13.2	13.0	24.4	15.3	29.5	35.3	6.2	18.8	13.8	2.0	7.9	5.9	9.6	8.7	11.0	9.2	10.8	11.6	17.8	8.2	11.2	11.6	0.8	13.9	7.6	8.1	11.3	7.1	10.5	12.1	15.0	10.5	8.4	9.5	8.3	11.8	13.6	7.9
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"			280000000	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: , HPA070293: "	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	40.2	23.7	19.0	49.4	18.1	33.5	35.0	8.1	22.6	53.5	53.3	25.8	38.4	39.2	80.9	54.2	59.6	54.9	57.6	49.5	19.6	20.5	55.4	41.3	41.7	57.4	22.1	17.1	51.5	22.2	19.5	18.6	40.4	26.8	47.1	38.3	37.6	38.5	49.1	32.1	31.6	54.5	88.0	19.5	46.9	41.1	38.0	16.0	74.5	49.9	36.4	50.2	69.6	41.5	22.9	40.2	54.2	61.2	32.5	55.6	64.1	30.2	30.3	27.2	22.8	20.6	34.3	43.0	76.4	70.5	69.1	54.3	36.2	38.2	21.0	24.9	91.2	19.8	29.5	55.9	73.9	32.8	10.1	60.0	31.1	25.7	48.4	19.0	69.6	32.9	28.7	70.1	35.1	74.2	17.9	35.0	66.9	17.3	83.8	26.8	32.2	30.5	39.6	24.9	17.8	43.1	48.2	9.2	10.0	32.6	18.1	31.4	15.2	20.7	111.6	53.3	22.4	44.1	66.9	22.1	35.4	27.6	56.4	28.9	66.1	37.1	29.0	54.2	48.3	51.7	37.4	22.9	40.6	48.2	37.8	16.9	41.7	44.4	54.1	32.5	61.2	40.2	55.6	64.1	19.0	18.1	8.1	22.6	19.6	20.5	22.1	17.1	26.8	16.0
ZNF497	FLJ44773	ENSG00000174586	"Zinc finger protein 497"	Q6ZNH5	19	58354357-58362848	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA047872	Uncertain		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA047872: "	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.24e-1)"	0.8	2.3	3.3	2.8	5.5	2.3	5.0	7.5	6.2	3.3	1.7	3.1	3.0	2.0	4.1	3.7	3.6	9.1	3.1	2.0	7.2	3.3	3.7	5.0	3.2	3.8	2.0	4.5	4.5	6.0	3.8	5.9	1.8	5.8	3.2	1.2	1.4	7.7	1.9	0.8	4.6	3.1	0.6	3.5	3.6	2.8	2.3	0.6	2.5	4.9	2.0	1.5	1.4	2.1	4.7	4.8	2.3	2.8	2.1	4.8	1.9	1.6	5.8	5.2	5.1	0.2	0.1	7.0	3.1	0.0	0.0	0.0	0.4	1.9	3.4	1.7	0.0	0.8	0.6	0.4	0.0	3.6	17.4	3.1	1.6	1.0	0.3	1.2	8.1	0.4	0.8	0.1	0.6	0.0	2.5	0.5	0.1	6.0	4.2	4.3	3.2	1.8	10.6	3.9	1.8	0.5	1.4	4.1	5.8	1.7	5.2	2.8	7.1	3.5	0.5	5.8	3.1	0.5	1.0	7.6	9.1	3.0	1.6	3.5	3.1	2.3	2.8	0.9	2.4	1.1	2.6	3.8	2.8	2.9	2.7	4.7	2.9	4.8	1.0	2.1	0.9	4.8	3.1	1.9	3.3	5.5	7.5	4.2	7.2	3.3	2.0	4.5	5.8	0.6
ZNF536	KIAA0390	ENSG00000198597	"Zinc finger protein 536"	O15090	19	30228290-30713538	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 44.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 3.9;HAP1: 8.7;SH-SY5Y: 23.8;U-937: 5.8;WM-115: 10.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077341			Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"HPA077341: "	"unprognostic (1.98e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.68e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.46e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.45e-1)"	1.1	6.0	9.9	2.0	21.0	0.6	0.8	14.3	24.1	4.2	4.0	44.5	0.0	2.7	1.7	1.3	6.9	1.0	1.3	2.9	13.3	7.7	0.8	0.7	1.0	0.7	20.9	9.6	0.9	0.9	0.7	3.4	0.7	18.3	3.7	4.1	4.8	1.6	2.4	1.4	1.2	4.2	1.2	23.1	1.5	2.1	5.0	18.4	0.0	6.9	0.0	0.7	2.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	8.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	23.8	0.0	0.0	1.5	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	5.8	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	21.0	14.3	15.1	13.3	7.7	20.9	9.6	18.3	18.4